AU2012265219A1 - Compounds containing hydrido-tricyano-borate anions - Google Patents

Compounds containing hydrido-tricyano-borate anions Download PDF

Info

Publication number
AU2012265219A1
AU2012265219A1 AU2012265219A AU2012265219A AU2012265219A1 AU 2012265219 A1 AU2012265219 A1 AU 2012265219A1 AU 2012265219 A AU2012265219 A AU 2012265219A AU 2012265219 A AU2012265219 A AU 2012265219A AU 2012265219 A1 AU2012265219 A1 AU 2012265219A1
Authority
AU
Australia
Prior art keywords
atoms
chain
straight
formula
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2012265219A
Other versions
AU2012265219B2 (en
AU2012265219A8 (en
Inventor
Eduard Bernhardt
Vera BERNHARDT-PITCHOUGINA
Tomohisa Goto
Nikolai Ignatyev (Mykola)
Kentaro Kawata
Michael Schulte
Helge Willner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2012265219A1 publication Critical patent/AU2012265219A1/en
Publication of AU2012265219A8 publication Critical patent/AU2012265219A8/en
Application granted granted Critical
Publication of AU2012265219B2 publication Critical patent/AU2012265219B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M10/00Secondary cells; Manufacture thereof
    • H01M10/05Accumulators with non-aqueous electrolyte
    • H01M10/056Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes
    • H01M10/0561Accumulators with non-aqueous electrolyte characterised by the materials used as electrolytes, e.g. mixed inorganic/organic electrolytes the electrolyte being constituted of inorganic materials only
    • H01M10/0563Liquid materials, e.g. for Li-SOCl2 cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10Energy storage using batteries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Secondary Cells (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Primary Cells (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Conductive Materials (AREA)

Abstract

The present invention relates to compounds containing hydrido-tricya-borate anions, their preparation and their use, in particular as part of electrolyte formulations for electrochemical or optoelectronic devices.

Description

WO 2012/163489 PCT/EP2012/002179 Compounds containing hydrido-tricyano-borate anions The present invention relates to compounds containing hydrido-tricyano borate anions, their preparation and their use, in particular as part of 5 electrolyte formulations for electrochemical or optoelectronic devices. The salts according to the invention can on the one hand be used for the synthesis of ionic liquids, on the other hand the salts can be employed per se as ionic liquid. 10 Ionic liquids or liquid salts are ionic species which consist of an organic cation and a generally inorganic anion. They do not contain any neutral molecules and usually have melting points below 373 K. 15 The area of ionic liquids is currently the subject of intensive research since the potential applications are multifarious. Review articles on ionic liquids are, for example, R. Sheldon "Catalytic reactions in ionic liquids", Chem. Commun., 2001, 2399-2407; M.J. Earle, K.R. Seddon "Ionic liquids. Green solvent for the future", Pure Appl. Chem., 72 (2000), 1391-1398; P. 20 Wasserscheid, W. Keim "lonische F10ssigkeiten - neue L6sungen for die Obergangsmetallkatalyse" [Ionic Liquids - Novel Solutions for Transition Metal Catalysis], Angew. Chem., 112 (2000), 3926-3945; T. Welton "Room temperature ionic liquids. Solvents for synthesis and catalysis", Chem. Rev., 92 (1999), 2071-2083 or R. Hagiwara, Ya. Ito "Room temperature 25 ionic liquids of alkylimidazolium cations and fluoroanions", J. Fluorine Chem., 105 (2000), 221-227. The properties of ionic liquids, for example melting point, thermal and electrochemical stability, viscosity, are strongly influenced by the nature of 30 the anion. E. Bernhardt et al, Z. Anorg. AlIg. Chem. 2000, 626, 560, E. Bernhardt et al, Chem. Eur. J. 2001, 7, 4696 and E. Bernhardt et al, Z. Anorg. AlIg. Chem. CONFIRMATION COPY WO 2012/163489 PCT/EP2012/002179 -2 2003, 629,1229 disclose the novel chemically and electrochemically stable borate anions [B(CN) 4 ]-, [FxB(CN) 4 .x]-, where x = 1 to 3, and [B(CF 3
)
4 ]~. EP 1205480 Al describes tetrakisfluoroalkylborate salts and the use there 5 of as conductive salts or ionic liquids. Compounds with dihydrido-dicyano-borate anions with organic cations such as N,N-dimethyl-N-butyl-hydrazinium, N,N-dimethyl-N-allyl-hydrazinium, 3 allyl-1-methylimidazolium, N-butylpyridinium, N-allylpyridinium, N-butyl-N 10 methyl-pyrrolidinium, N-allyl-N-methylpyrrolidinium, 1-butyl-3 methyltriazolium or 1-allyl-3-methyltriazolium cations are known from Zhang Y. and Shreeve J.M. , Angew. Chem. 2011, vol. 123, p. 965-967. The above mentioned organic salts are synthesized via anion exchange reaction with Ag[BH 2
(CN)
2 ]. 15 But, silver salts are expensive materials. They are light sensitive, thermally not very stable and are not useful starting materials for industrial scale production of various salts, in particular the salts having organic cations and thus forming ionic liquids. 20 The object of the present invention was to provide alternative compounds which are novel, thermally and electrochemically stable which can be used for the synthesis of ionic liquids or as ionic liquids or as conductive salts, and which are in particular useful for the synthesis of ionic liquids or as 25 ionic liquids or organic salts for application in electrochemical or optoelectronic devices. The object of the present invention was furthermore to provide a method for the preparation of the alternative salts, especially the compounds of formula 1, as described below, which can be produced in economical way on industial scale. 30 WO 2012/163489 PCT/EP2012/002179 -3 The object is achieved by the salts of the formula I according to the invention with hydrido-tricyano-borate anions and the described methods for their preparation. 5 The invention therefore relates to compounds of formula I [Kt]z+ z[BH(CN) 3 ]~ I in which [Kt]z+ denotes an inorganic or organic cation and z is 1, 2, 3 or 4, where sodium hydrido-tricyano-borate, potassium hydrido-tricyano-borate, silver hydrido-tricyano-borate and [(Phenyl) 3 P-N=N-P(Phenyl) 3 ]hydrido 10 tricyano-borate are excluded. The term tricyano-hydridoborate is used within the description equally to tricyanomonohydridoborate, hydrido-tricyanoborate or monohydridotricyanoborate. 15 CN 1772728A describes a process for the preparation of N phenylhydroxylamine derivatives through reduction of nitobenzenes in which the reducing agent is described as being sodium borohydride, potassium borohydride, sodium hydrido-tricyano-borate, potassium hydrido 20 tricyano-borate, sodium hydrogen selenide or selenium potassium hydride. The synthesis of the sodium hydrido-tricyano-borate or potassium hydrido tricyano-borate is not mentioned within this citation. B. Gy~ri et al, Journal of Organometallic Chemistry, 255, 1983, 17-28 25 describes the isomerisation of sodium triisocyanohydroborate (adduct with 0.5 mol of dioxane) to sodium hydrido-tricyano-borate in boiling n-dibutyl ether and a preparation of silver hydrido-tricyano-borate through reaction of sodium hydrido-tricyanoborate with an aqueous solution of silver nitrate. 30 H. Yao et al, Inorg. Chem. 2005, 44, 6256-6264 describes the synthesis of silver triisocyanohydroborate (Ag[HB(NC) 3 ]) through reaction of Me 2 S*BHBr 2 in Me 2 S with AgCN in Me 2 S. The abbreviation Me means in WO 2012/163489 PCT/EP2012/002179 -4 this citation methyl. The crude material was reacted in a metathesis reaction with PPNCl forming [(Phenyl) 3 P-N=N-P(Phenyl) 3 ] triisocyanohydroborate (PPN[HB(NC) 3 ]) which is then isomerised to [(Phenyl) 3 P-N=N-P(Phenyl) 3 ]hydrido-tricyano-borate in boiling n-butyl ether. 5 The cation [Kt]z+ may be inorganic, in particular a metal cation, H* or NO+. The metal cation may comprise metals from groups 1 to 12 of the Periodic Table. Preferred metal cations are metal cations, such as Li*, Na*, K*, Rb*, Cs*, or 10 Mg2+, Cu*, Cu 2 +, Zn2+,Ca2+ y+3, Yb+3, La+ 3 , Sc+ 3 , Ce+3, Nd+3, Tb+3, Sm+ 3 or complex (ligands containing) metal cations which include rare-earths, transitions or noble metals like rhodium, ruthenium, iridium, palladium, platinum, osmium, cobalt, nickel, iron, chromium, molybdenum, tungsten, vanadium, titanium, zirconium, hafnium, thorium, uranium, gold, where 15 sodium hydrido-tricyano-borate, potassium hyd rido-tricyano-borate or silver hydrido-tricyano-borate is excluded from the scope of the invented compounds but still included for the described methods for the preparations. The alkali metal is preferably lithium which is preferably used as conducting salt and/or component of electrolytes for application in 20 batteries, capacitors, sensors or for electrochemical processes, and sodium or potassium which is preferably used for the synthesis of compounds of formula I as described above and below in which the cation [Kt]z+ is a cation other than the used sodium or the used potassium, especially preferably for compounds of formula I in which the cation [Kt]z+ is an organic cation. 25 If [Kt]z+ is an organic cation, the organic cation is preferably selected from the group comprising iodonium, tritylium, sulfonium, oxonium, ammonium, phosphonium, uronium, thiouronium, guanidinium cations or heterocyclic cations. 30 Examples of organic cations are also polyammonium ions having a degree of charging of 4 which means z denotes 4.
WO 2012/163489 PCT/EP2012/002179 -5 Preferred compounds of formula I are compounds, in which Ktz denotes an inorganic cation selected from the group of H', NO*, Li*, Mg2+, Cu*, Cu 2 +, Zn 2+ ,Ca2+, y+3, Yb+3, La+ 3 , Sc+ 3 , Ce+3, Nd+3, Tb+ 3 , Sm+3 5 or complex (ligands containing) metal cations which include rare-earths, transitions or noble metals like rhodium, ruthenium, iridium, palladium, platinum, osmium, cobalt, nickel, iron, chromium, molybdenum, tungsten, vanadium, titanium, zirconium, hafnium, thorium, uranium, gold, 10 or an organic cation selected from the group of tritylium cation, in which the phenyl groups may be substituted by straight chain or branched alkyl groups having 1 to 20 C atoms, straight-chain or branched alkenyl having 2 to 20 C atoms and one or more double bonds or straight-chain or branched alkynyl having 2 to 20 C atoms and 15 one or more triple bonds, an oxonium cation of formula (1) or a sulfonium cation of formula (2)
[(R*)
3 0]* (1)
[(R*)
3 S]* (2), where R* each independently of one another denotes a straight-chain 20 or branched alkyl group having 1-8 C atoms, non-substituted phenyl or phenyl which is substituted by R 1 , OR', N(R') 2 , CN or halogen and in case of sulfonium cations of formula (2) additionally denotes each independently (R.') 2 N and R' is independently of each other H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or 25 branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non substituted or substituted phenyl, R1* is independently of each other non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non substituted or substituted phenyl and R.' is independently of each other 30 straight-chain or branched C 1 to C 6 alkyl; an ammonium cation, which conforms to the formula (3) WO 2012/163489 PCT/EP2012/002179 -6 [NR4]* (3), where R in each case, independently of one another, denotes H, OR', N(R') 2 , with the proviso that a maximum of one R in formula (3) 5 is OR' or N(R') 2 , straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or 10 more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two R may be fully substituted by halogens, in particular 15 -F and/or -Cl, and one or more of the substituents R may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -CN, -N(R') 2 , -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 ,
-SO
2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, -NO 2 , -SR', -S(O)R', -SO 2 R' and where one or two non-adjacent carbon atoms in R which are not in the 20 a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -S02-, -SO 2 0-, -C(O)-, -C(O)O-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-,
-P(R')
2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or 25 branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non substituted or substituted phenyl and X each independently is halogen; a phosphonium cation, which conforms to the formula (4) [P(R 2 4+ (4) where 30 R 2 in each case, independently of one another, denotes H, OR' or N(R') 2 , straight-chain or branched alkyl having 1-20 C atoms, WO 2012/163489 PCT/EP2012/002179 -7 straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, 5 saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two R 2 may be fully substituted by halogens, in particular -F and/or -Cl, and one or more of the substituents R 2 may be partially 10 substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -CN, -N(R') 2 , -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 ,
-SO
2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, -NO 2 , -SR', -S(O)R', -SO 2 R' and where one or two non-adjacent carbon atoms in R 2 which are not in the a-position may be replaced by atoms and/or atom groups selected from 15 the group -0-, -S-, -S(O)-, -SO 2 -, -S0 2 0-, -C(O)-, -C(O)O-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-,
-P(R')
2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 1 8 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non 20 substituted or substituted phenyl and X each independently is halogen; a uronium cation, which conforms to the formula (5)
[C(NR
3
R
4
)(OR
5
)(NR
6
R*
7 )] (5), where 25 R 3 to R 7 each, independently of one another, denote H, where H is excluded for R 5 , straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 30 straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, WO 2012/163489 PCT/EP2012/002179 -8 saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two of the substituents R 3 to R 7 may be fully substituted 5 by halogens, in particular -F and/or -Cl, and one or more of the substituents R 3 to R 7 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non-adjacent carbon 10 atoms in R 3 to R 7 which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -SO2-, -SO20-, -C(O)-, -C(O)O-, -N*(R')2-, -P(O)R'O-, -C(O)NR'-,
-SO
2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or 15 perfluorinated straight-chain or branched C 1 - to C 18 -alkyl, saturated C 3 to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen; a thiouronium cation, which conforms to the formula (6) 20 [C(N R 3
R
4
)(SR
5
)(NR
6
R*
7 )]+ (6), where
R
3 to R 7 each, independently of one another, denote H, where H is excluded for R , straight-chain or branched alkyl having 1 to 20 C atoms, 25 straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, 30 which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, WO 2012/163489 PCT/EP2012/002179 -9 where one or two of the substituents R 3 to R 7 may be fully substituted by halogens, in particular -F and/or -Cl, and one or more of the substituents R 3 to R 7 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, 5 C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non-adjacent carbon atoms in R 3 to R 7 which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-,
-SO
2 -, -S020-, -C(O)-, -C(0)0-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-, 10 -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C1- to C1 8 -alkyl, saturated C3 to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen; 15 a guanidinium cation, which conforms to the formula (7) [C(NR 8R9)(NR10R")(NR 12R 1)]* (7), where
R
8 to R1 3 each, independently of one another, denote 20 H, -CN, N(R') 2 , -OR', straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or 25 more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two of the substituents R 8 to R 13 may be fully substituted 30 by halogens, in particular -F and/or -Cl, and one or more of the substituents R 8 to R1 3 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, - WO 2012/163489 PCT/EP2012/002179 - 10 C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non-adjacent carbon atoms in R 8 to R 13 which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, 5 SO 2 -, -S020-, -C(O)-, -C(O)O-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-,
-SO
2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'-, where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C1 8 -alkyl, saturated C3- to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each 10 independently is halogen; a heterocyclic cation which conforms to the formula (8) [HetN]+ (8) where 15 HetNz+ denotes a heterocyclic cation selected from the group imidazolium 1H-pyrazolium 3H-pyrazolium 4H-pyrazolium 1-pyrazolinium RZ Rz R 2
R
2 ' R 2 ' R R2 R 2
R
2 ' R 2 ' R 2 ' -4 R 3 ' RT RX RT 20 R2 ZR 4 , RN ,N N R, 2-pyrazolinium 3-pyrazolinium 2,3-dihydroimidazolinium 4,5-dihydroimidazolinium
R
2 ' R R2 R 2 ' R 2 ' R 2 ' R2 RT R 7
R
3 RX RX + R R3 N- N N N, R2 N R 4 Rz N\ R 4 R4 R R4 R" R" R R R 2 25 2,5-dihydroimidazolinium pyrrolidinium 1,2,4-triazolium 1,2,4-triazolium 1,2,3-triazolium R3- R R 3 R2' R2' R4 R R 4 ' R"
R
2
R
3 N N N-N+ N N ., RR N- R 4 , ,N
R
1 ' Rz N+ R 3 ' Rz 2 N + Rz N R2
R
3 Rz R" R 4 ' , R" R R 30 WO 2012/163489 PCT/EP2012/002179 -11 pyridinium pyridazinium pyrimidinium 1,2,3-triazolium piperidinium 5~ R R R z R R 2 * R zR2' Rz RR R3 RR R R z R,, R RN RT R R" RR 4+ R , R 2 ' R + Rz R, R Rr R R 2' R " R " 2 R4' morpholinium piperazinium piperazinium pyrazinium thiazolium R RN Rr R " NRN +N R \+ Rz N R+ RT Rz 1R 3 '5 R 1 R , R R 3 1 , R, N>' R2R >K ZR 3 - ~ ~NR /\+ R 3 1 Rz /\+ R'R 2 ' N + 2 N z RR\+ R 3 ' R R 2 '4 RRr R 4 ' R R indolium quinolinium isoquinolinium oxazolum R R 2 Rz RR' RR
R
2 ' R+ R3R 20R R R 4 ,'R - ,' Rk Rz R R 0 ,,N N" R2 N NN_ 2+ RR R' I R2 R 2 ' + R" 15 RO R 2 R 4 ' R R O Rz R2 quinoxalinium indolinium benzimidazolium Pyrylium Rr OR2 R2 R2'
R
2 I R2 R '' '. - R 2 \z /R R 20 to R4 en f o 30hsroaiht-hanzorym branchoalylhing 12-20zCyaom s,
R
2 RZ
R
2 ' 2RRZ 25 1 + Rz~ R 2 ' R 3' R 2 orR 2 ' R z R where the substituents
R
1 ' to R 4 ' each, independently of one another, denote H, 30 straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, WO 2012/163489 PCT/EP2012/002179 - 12 straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups 5 having 1-6 C atoms, saturated, partially or fully unsaturated heteroaryl, heteroaryl-C-C 6 alkyl or aryl-C-Cs-alkyl and
R
2 denote additionally F, Cl, Br, I, -CN, -OR', -N(R') 2 , -P(O)(R') 2 , P(O)(OR') 2 , -P(O)(N(R') 2
)
2 , -C(O)R', -C(O)OR', -C(O)X, -C(O)N(R') 2 , 10 SO 2
N(R')
2 , -SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R' and/or NO 2 , with the proviso that R"', R 3 ', R 4 ' are in this case independently of each other H and/or a straight-chain or branched alkyl having 1-20 C atoms, straight chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 15 where the substituents R", R 2 , R 3 and/or R4' together may also form a ring system, where one to three substituents R" to R4' may be fully substituted by halogens, in particular -F and/or -Cl, and one or more substituents R' 20 to R4' may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', N(R') 2 , -CN, -C(O)OH, -C(O)OR', -C(O)R', C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -SO 2 OH, -SO 2 X, -SR', -S(O)R', SO 2 R', -NO 2 , but where R" and R4' cannot simultaneously be fully substituted by halogens and where, in the substituents R" to R 4 , one or 25 two non-adjacent carbon atoms which are not bonded to the heteroatom may be replaced by atoms and/or atom groups selected from the -0-, -S-, -S(O)-, -SO 2 -, -S0 2 0-, -C(O)-, -C(0)0-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-,
-P(R')
2 =N- or -P(O)R'-, 30 where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C 18 -alkyl, saturated WO 2012/163489 PCT/EP2012/002179 - 13
C
3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen or a iodonium cation which conforms to the formula (9) 5 Ar-I-Ar (9) where the aryl group Ar denotes each independently of each other aryl with 6 to 30 C atoms which is non-substituted or substituted with at least a 10 straight-chain or branched alkyl group having 1 to 20 C atoms, a straight-chain or branched alkenyl group having 2 to 20 C atoms and one or more double bonds, a straight-chain or branched alkynyl group having 2 to 20 C atoms and one or more triple bonds, Rl*, NO 2 , SR',
N(R')
2 , CN and/or halogen and 15 where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 18 -alkyl, saturated
C
3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl and where R 1 each independently is non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C 18 -alkyl, saturated C 3 20 to C 7 -cycloalkyl, non-substituted or substituted phenyl and halogen is F, Cl, Br or I. Halogen is preferably F, Cl or Br, particularly preferably F or Cl. 25 The compounds of formula I having organic cations are posessing low viscosity. Some of the viscosities are even lower compared with the corresponding tetracyanoborates having the same organic cation. For example, 1-ethyl-3-methyl-imidazolium tetracyanoborate (emim TCB) has 30 the dynamic viscosity of 22 mPas (at 20 0 C) and the corresponding 1-ethyl 3-methyl-imidazolium hydrido-tricyano-borate has a viscosity of 12.2 mPas (at 20 0 C). In addition, the thermal stability of such compounds is higher WO 2012/163489 PCT/EP2012/002179 - 14 compared to compounds with organic cations with dihydrido-dicyano-borate anions or difluorodicyanoborate anions. For example, emim difluoro dicyanoborate has a thermal stability up to 160 *C, emim dihydrido-dicyano borate shows a thermal stability up to 230 *C and emim hydrido 5 tricyanoborate has a thermal stability up to 277 *C which is comparable to the stability of emim TCB. The positive influence of the replacement of one cyano-group with hydrogen on the viscosity of compounds of formula I compared to the compounds with tetracyanoborate anions is unexpected. In comparison to electron-withdrawing groups like fluor, perfluoroalkyl or 10 cyano groups which are able to effectively delocalise the negative charge of borate anions, hydrogen practically does not participate in the stabilization of borate-anion. The introduction of one hydrogen atom to Boron should increase the coordination ability of the tricyano-hydrido borate anion, causing increase in the viscosity of ionic liquids with this anion. But the 15 experimental results are totally opposite from the theoretical point of view. Not being bound by that theory, it seams that the introduction of one hydrogen atom to Boron breaks the symmetry of tetracyano-borate anion resulting in strong decreasing of ionic liquids viscosity. 20 Another advantage of compounds of formula I is that they can be prepared from commercially available starting materials via a simple reaction protocol.
R
0 of the [(R 0
)
3 0]* cation (formula (1)) is preferably straight-chain alkyl 25 having 1-8 C atoms, preferably having 1-4 C atoms, in particular methyl or ethyl, very particularly preferably ethyl.
R
0 of the [(R*) 3 S]* cation (formula (2)) is preferably straight-chain alkyl having 1-8 C atoms, preferably having 1-4 C atoms, in particular methyl or 30 ethyl, very particularly preferably ethyl. This definition is preferably for the technical application as component of an electrolyte.
WO 2012/163489 PCT/EP2012/002179 - 15 At least one subsitutent R 0 within the sulfonium cations of formula (2) is preferably phenyl or substituted phenyl in case the sulfonium cation is chosen together with the inventive anion as cationic polymerization initiator, photo-polymerization initiator or photo-acid generator. Particularly 5 preferably all substituents R 0 in formula (2) are for this application each independently phenyl and/or phenyl substituted with SR' where R' has a meaning as described before. Preferred cations of formula (2) for this application are triphenylsulfonium, 10 diphenyltolylsulfonium, diphenylethylsulfonium, diphenyl-2,2,2-trifluorethyl sulfonium, diphenyl-2-ethoxy-ethylsulfonium, diphenyl-2 chlorethylsulfonium, diphenyl-3-brompropylsulfonium, diphenyl-3 chlorpropylsulfonium, diphenyl-3-cyanopropylsulfonium, diphenylallylsulfonium, diphenyl-4-pentenylsulfonium, 15 diphenylpropargylsulfonium, diphenylbenzylsulfonium, diphenyl(p cyanobenzyl)sulfonium, diphenyl(p-methylbenzyl)sulfonium, diphenyl(p phenylthiobenzyl)sulfonium, diphenyl(3,3-dicyano-2-phenyl-2 propenyl)sulfonium, diphenyl(p-methylphenacyl)sulfonium, diphenyl(ethylcarboxy)methylsulfonium, diphenyl(n-octyl)sulfonium, 20 diphenyl(n-octadecyl)sulfonium, diphenyl(w-carboxytridecyl)sulfonium, diphenyl(3-oxypropyl)sulfonium, diphenyl(w-carboxydodecyl)sulfonium, dihexyl-phenylsulfonium, ditolylphenylsulfonium, tritolylsulfonium, m- or p (tert-butyl)phenyl-diphenylsulfonium, m- or p-methoxyphenyl diphenylsulfonium, m- or p-CN-phenyl-diphenylsulfonium, m- or p-C 6 Hl 3
S
25 phenyl-diphenylsulfonium, m- or p-C 6
H
5 S-phenyl-diphenylsulfonium, Tri(p methoxyphenyl)sulfonium, tri[4-(4-acetyl-phenylsulfanyl)phenyl]sulfonium, tri(4-tert.-butylphenyl)sulfonium. For the purposes of the present invention, fully unsaturated cycloalkyl 30 substituents are also taken to mean aromatic substituents.
WO 2012/163489 PCT/EP2012/002179 - 16 In accordance with the invention, suitable substituents R and R 2 to R' 3 of the compounds of the formulae (3) to (7) are preferably: H, C- to C 20 -, in particular C- to C 14 -alkyl groups, and saturated or unsaturated, i.e. also aromatic, C 3 - to C 7 -cycloalkyl groups, which may be substituted by C- to 5 C 6 -alkyl groups, in particular phenyl which may be substituted by C- to C 6 alkyl groups. The substituents R and R 2 in the compounds of the formula (3) or (4) may be identical or different. The substituents R and R 2 are preferably different. 10 The substituents R and R 2 are particularly preferably methyl, ethyl, iso propyl, propyl, butyl, sec-butyl, pentyl, hexyl, octyl, decyl or tetradecyl. Up to four substituents of the guanidinium cation 15 [C(NR 8
R
9
)(NR
0
R
1 )(NR1 2
R
13 )]* may also be bonded in pairs in such a way that mono-, bi- or polycyclic cations are formed. Without restricting generality, examples of such guanidinium cations are:
R
8
R
9
R
8
R
9
R
8
R
9
R
8
R
9 /N N \N/ N + \N/ N + 20 R 13 + R1 3 -N N-R1 0
R
13 + R13 N N 20 R1 N N * N N--R 1 O N N''-- RI 'N N'_ RI
R
8
R
9
R
8
R
9 25 N N---R1 N N R a R 9 + + R 8
R
9
N
1 N N NR1'O N N RIO 25 + + N N R'N -_ NI N
R
8
R
9
R
8
R
9 N+ \N/ 30 N NR 1 3 30 N N ' NRI C )or N=N WO 2012/163489 PCT/EP2012/002179 - 17 where the substituents R 8 to R 10 and R1 3 can have a meaning or particularly preferred meaning indicated above. If desired, the carbocycles or heterocycles of the guanidinium cations indi cated above may also be substituted by straight-chain or branched C- to 5 C 6 -alkyl, straight-chain or branched C- to C 6 -alkenyl, -CN, -NO 2 , F, Cl, Br, I, OH, straight-chain or branched C-C6-alkoxy, -N(R') 2 , -SR', -S(O)R', SO 2 R', -COOH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, SO 2 X, -SO 3 H, substituted or non-substituted phenyl or a non-substituted or substituted heterocycle, where X and R' have a meaning indicated above. 10 Up to four substituents of the uronium cation [C(NR 3
R
4
)(OR
5
)(NR
6
R
7 )]* or thiouronium cation [C(NR 3
R
4
)(SR
5
)(NR
6 R 7 )] may also be bonded in pairs in such a way that mono-, bi- or polycyclic cations are formed. 15 Without restricting generality, examples of such cations are indicated below, where Y = 0 or S: RS R 5 5R5 R 5 Y Y Y + Y +
R
3 + R 3 ' N N-- R 6
R
3 + R 3 'N N R 6 20 N N-'--R 6 N N-R 6
R
5
R
5 I I R5 Y Y +R 5 I R3N N'-R R 3 N N'R6 I 25 N N R 6 N N 5 R5 Y + Y 30 N R 3 , -- R 6 or N=N WO 2012/163489 PCT/EP2012/002179 - 18 where the substituents R 3 , R 5 and R 6 can have a meaning or particularly preferred meaning indicated above. If desired, the carbocycles or heterocycles of the cations indicated above may also be substituted by straight-chain or branched C1- to C 6 -alkyl, 5 straight-chain or branched C1- to C 6 -alkenyl, -CN, -NO 2 , F, Cl, Br, I, OH, straight-chain or branched C1-C 6 -alkoxy, -N(R') 2 , -SR', -S(O)R', -SO 2 R', -COOH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -SO 2 X, SO 3 H, substituted or non-substituted phenyl or a non-substituted or substituted heterocycle, where X and R' have a meaning indicated above. 10 The substituents R 3 to R 13 are each, independently of one another, prefera bly a straight-chain or branched alkyl group having 1 to 16 C atoms. The substituents R 3 and R 4 , R 6 and R 7 , R 8 and R 9 , R 10 and R" and R 12 and R 13 in compounds of the formula (5) to (7) may be identical or different. R 3 to 15 R are particularly preferably each, independently of one another, methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, sec-butyl, phenyl, hexyl or cyclohexyl, very particularly preferably methyl, ethyl, n-propyl, iso-propyl, n-butyl or hexyl. 20 In accordance with the invention, suitable substituents R' to R 4 of com pounds of the formula (8) are each, independently of one another, preferably, H, straight-chain or branched alkyl having 1 to 20 C atoms, which optionally 25 may be fluorinated or perfluorinated, straight-chain or branched alkenyl having 2 to 20 C atoms and one or more double bonds, which optionally may be fluorinated, straight-chain or branched alkynyl having 2 to 20 C atoms and one or more triple bonds which optionally may be fluorinated or 30 straight-chain or branched alkoxyalkyl having 2 to 8 C atoms, with the assumption that R" and R4'are not simultaneously be perfluorinated.
WO 2012/163489 PCT/EP2012/002179 - 19 The substituents R" and R4' are each, independently of one another, particularly preferably straight-chain or branched alkyl having 1 to 20 C atoms, which optionally may be fluorinated or perfluorinated or straight 5 chain or branched alkoxyalkyl having 2 to 8 C atoms with the assumption that R" and R4'are not perfluorinated at the same time. The substituents R" and R4' are each, independently of one another, par ticularly preferably methyl, ethyl, allyl, iso-propyl, propyl, butyl, sec-butyl, tert-butyl, n-pentyl, n-hexyl, n-octyl, n-decyl, cyclohexyl, methoxyethyl, 10 methoxymethyl, ethoxyethyl, ethoxymethyl, phenyl or benzyl. They are very particularly preferably methyl, ethyl, propyl n-butyl or methoxyethyl. In pyrrolidinium, piperidinium or indolinium compounds, the two substituents R' and R 4 are preferably different. 15 In accordance with the invention, suitable substituents R 2 and R 3 of compounds of formula (8) are particularly preferably: H, straight-chain or branched C- to C 20 -, in particular C- to C 12 -alkyl groups, and saturated or unsaturated, i.e. also aromatic, C 3 - to C 7 -cycloalkyl groups, which may be substituted by straight-chain or branched C 1 - to C 6 -alkyl groups, in 20 particular phenyl. The substituent R 2 or R 3 is in each case, independently of one another, in particular H, methyl, ethyl, iso-propyl, propyl, butyl, sec-butyl, tert-butyl, cyclohexyl, phenyl or benzyl. R 2 is particularly preferably H, methyl, ethyl, 25 iso-propyl, propyl, butyl or sec-butyl. R 3 is particularly preferably H. R 2 ' and RTare very particularly preferably H. A straight-chain or branched alkyl having 1-20 C atoms denotes an alkyl group having 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 30 20 C atoms, for example methyl, ethyl, iso-propyl, n-propyl, iso-butyl, n butyl, tert-butyl, n-pentyl, 1-, 2- or 3-methylbutyl, 1,1-, 1,2- or 2,2 dimethylpropyl, 1-ethylpropyl, n-hexyl, n-heptyl, n-octyl, ethylhexyl, n-nonyl, WO 2012/163489 PCT/EP2012/002179 - 20 n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl or eicosyl, which optionally may be fluorinated or perfluorinated. The term "perfluorinated" means that all H atoms are substituted by F atoms in the given alkyl group. 5 The term "fluorinated" means that at least one H atom of the given alkyl group is substituted by an F atom. A straight-chain or branched alkenyl having 2 to 20 C atoms, in which a plu rality of double bonds may also be present, is, for example, allyl, 2- or 3 10 butenyl, iso-butenyl, sec-butenyl, furthermore 4-pentenyl, iso-pentenyl, hex enyl, heptenyl, octenyl, -CqH1 7 , -C 10
H
1 9 to -C 20
H
39 , preferably allyl, 2- or 3 butenyl, iso-butenyl, sec-butenyl, furthermore preferably 4-pentenyl, iso pentenyl or hexenyl, which may be optionally partially fluorinated. 15 A straight-chain or branched alkynyl having 2 to 20 C atoms, in which a plu rality of triple bonds may also be present, is, for example, ethynyl, 1- or 2 propynyl, 2- or 3-butynyl, furthermore 4-pentynyl, 3-pentynyl, hexynyl, hept ynyl, octynyl, -C 9
H
15 , -C 10
H
17 to -C 2 0
H
37 , preferably ethynyl, 1- or 2-propyn yl, 2- or 3-butynyl, 4-pentynyl, 3-pentynyl or hexynyl, which may be 20 optionally partially fluorinated. A straight-chain or branched alkoxyalkyl having 2 to 12 C atoms is, for example, methoxymethyl, 1-methoxyethyl, 1-methoxypropyl, 1-methoxy-2 methyl-ethyl, 2-methoxy-propyl, 2-methoxy-2-methyl-propyl, 1 25 methoxybutyl, 1-methoxy-2,2-dimethyl-ethyl, 1-methoxy-pentyl, 1 methoxyhexyl, 1-methoxy-heptyl, ethoxymethyl, 1-ethoxyethyl, 1 ethoxypropyl, 1-ethoxy-2-methyl-ethyl, 1-ethoxybutyl, 1-ethoxy-2,2 dimethyl-ethyl, 1-ethoxypentyl, 1-ethoxyhexyl, 1-ethoxyheptyl, propoxymethyl, 1-propoxyethyl, 1-propoxypropyl, 1-propoxy-2-methyl-ethyl, 30 1-propoxybutyl, 1-propoxy-2,2-dimethyl-ethyl, 1-propoxypentyl, butoxymethyl, 1-butoxyethyl, 1-butoxypropyl or 1-butoxybutyl. Particularly WO 2012/163489 PCT/EP2012/002179 - 21 preferred is methoxymethyl, 1-methoxyethyl, 2-methoxy-propyl, 1 methoxypropyl, 2-methoxy-2-methyl-propyl or 1-methoxybutyl. Aryl with 6 to 30 C atoms denotes an aryl group with 6 to 30 C atoms and is 5 an aromatic group with aromatic delocalized electrons, optionally subsituted one or more times by R 1 , OR', N(R') 2 , CN, NO 2 or halogen. An aryl group with 6 to 30 C atoms, preferably with 6 to 24 C atoms, is for example 1-, 2-, 3-, 4-, 5- or 6-phenyl, 1-, 2-, 3-, 4-, 6-, 7- or 8-naphthyl, 1-, 2-, 3-, 4-, 6-, 7 or 8-phenanthrenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-anthracenyl, 1-, 2-, 10 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-tetracenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-benzo[a]anthracenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13- or 15-pentacenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12 chrysenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-pyrenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7 , 8-, 9-, 10-, 11- or 12-benzo[a]pyrenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7- or 8-azulenyl, 15 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-fluoranthenyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11- or 12-perylenyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-indenyl or 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-fluorenyl which is preferably non-substituted or substituted by R 1 , OR', N(R) 2 , CN or halogen. Preferably, aryl denotes 1-, 2-, 3-, 4-, 5 or 6-phenyl, 1-, 2-, 3-, 4-, 6-, 7- or 8-naphthyl which is non-substituted or 20 substituted by Rl*, OR', N(R') 2 , CN or halogen. R 1 and R' have a meaning as described above. Aryl-C 1
-C
6 -alkyl denotes, for example, benzyl, phenylethyl, phenylpropyl, phenylbutyl, phenylpentyl or phenylhexyl, where both the phenyl ring and 25 also the alkylene chain may be partially or fully substituted, as described above, by halogens, in particular -F and/or -Cl, or partially by -OH, -OR',
-N(R')
2 , -CN, -C(O)OH, -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, -C(O)OR', C(O)R', -SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R', -NO 2 and R' and X have a meaning as described above. 30 Non-substituted saturated or partially or fully unsaturated cycloalkyl groups having 3-7 C atoms are therefore cyclopropyl, cyclobutyl, cyclopentyl, WO 2012/163489 PCT/EP2012/002179 - 22 cyclohexyl, cycloheptyl, cyclopentenyl, cyclopenta-1,3-dienyl, cyclohexenyl, cyclohexa-1,3-dienyl, cyclohexa-1,4-dienyl, phenyl, cycloheptenyl, cyclo hepta-1,3-dienyl, cyclohepta-1,4-dienyl or cyclohepta-1,5-dienyl, each of which may be substituted by straight-chain or branched C 1 - to C 6 -alkyl 5 groups, where the cycloalkyl group or the cycloalkyl group substituted by straight-chain or branched C 1 - to C 6 -alkyl groups may in turn also be substituted by halogen atoms, such as F, Cl, Br or I, in particular F or Cl, or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, -C(O)N(R') 2 , -SO 2
N(R')
2 , -C(O)X, C(O)OR', -C(O)R', -SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R', -NO 2 and R' and 10 X have a meaning as described above. In the substituents R, R 2 to R 13 or R" to R 4 , one or two non-adjacent car bon atoms which are not bonded in the c-position to the heteroatom may also be replaced by atoms and/or atom groups selected from the group -0-, 15 -S-, -S(0)-, -SO2-, -SO20-, -C(0)-, -C(0)O-, -N*R'2-, -P(O)R'O-, -C(O)NR'-,
-SO
2 NR'-, -OP(O)R'O-, -P(O)(NR' 2 )NR'-, -PR' 2 =N- or -P(O)R'-, where R' is non-fluorinated, partially fluorinated or perfluorinated C1- to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl. 20 Without restricting generality, examples of substituents R, R 2 to R1 3 and R 1 to R4' modified in this way are:
-OCH
3 , -OCH(CH 3
)
2 , -CH 2 0CH 3 , -CH 2
-CH
2 -0-CH 3 , -C 2
H
4 0CH(CH 3
)
2 ,
-C
2
H
4
SC
2
H
5 , -C 2
H
4
SCH(CH
3
)
2 , -S(O)CH 3 , -SO 2
CH
3 , -S0 2
C
6
H
5 , -S0 2
C
3
H
7 ,
-SO
2
CH(CH
3
)
2 , -SO 2
CH
2
CF
3 , -CH 2
SO
2
CH
3 , -O-C 4
H
8
-O-C
4
H
9 , -CF 3 , -C 2
F
5 , 25 -C 3
F
7 , -C 4 Fq, -C(CF 3
)
3 , -CF 2
SO
2
CF
3 , -C 2
F
4
N(C
2
F
5
)C
2
F
5 , -CHF 2 , -CH 2
CF
3 ,
-C
2
F
2
H
3 , -C 3
FH
6 , -CH 2
C
3
F
7 , -C(CFH 2
)
3 , -CH 2 C(O)OH, -CH 2
C
6
H
5 , -C(O)C 6
H
5 or P(O)(C 2
H
5
)
2 . In R' or R 1 , C 3 - to C 7 -cycloalkyl is, for example, cyclopropyl, cyclobutyl, 30 cyclopentyl, cyclohexyl or cycloheptyl.
WO 2012/163489 PCT/EP2012/002179 - 23 In R' or R 1 , substituted phenyl denotes phenyl which is substituted by straight-chain or branched C- to C 6 -alkyl, straight-chain or branched C- to
C
6 -alkenyl, -CN, -NO 2 , F, Cl, Br, I, -OH, straight-chain or branched-C-C 6 alkoxy, N(R") 2 , -COOH, -C(O)OR", -C(O)R", -SO 2 X', -SR", -S(O)R", 5 SO 2 R", SO 2
N(R")
2 or SO 3 H, where X' denotes F, CI or Br and R" denotes a non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C 6 -alkyl or C3- to C 7 -cycloalkyl as defined for R', for example o-, m- or p-methylphenyl, o-, m- or p-ethylphenyl, o-, m- or p-propylphenyl, o-, m- or p-isopropylphenyl, o-, m- or p-tert-butylphenyl, o-, 10 m- or p-nitrophenyl, o-, m- or p-hydroxyphenyl, o-, m- or p-methoxyphenyl, o-, m- or p-ethoxyphenyl, o-, m-, p-(trifluoromethyl)phenyl, o-, m-, p-(tri fluoromethoxy)phenyl, o-, m-, p-(trifluoromethylsulfonyl)phenyl, o-, m- or p-fluorophenyl, o-, m- or p-chlorophenyl, o-, m- or p-bromophenyl, o-, m- or p-iodophenyl, further preferably 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethyl 15 phenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dihydroxyphenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-difluorophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dichloro phenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dibromophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethoxyphenyl, 5-fluoro-2-methylphenyl, 3,4,5-trimethoxy phenyl or 2,4,5-trimethylphenyl. 20 In R" to R 4 ', heteroaryl is taken to mean a saturated or unsaturated mono or bicyclic heterocyclic group having 5 to 13 ring members, in which 1, 2 or 3 N and/or 1 or 2 S or 0 atoms may be present and the heterocyclic radical may be mono- or poly-substituted by straight-chain or branched C- to C 6 25 alkyl, straight-chain or branched C- to C 6 -alkenyl, -CN, -NO 2 , F, Cl, Br, I, OH, -N(R") 2 , straight-chain or branched C-C 6 -alkoxy, -COOH, -C(O)OR", C(O)R", -SO 2 X', -SO 2
N(R")
2 , -SR", -S(O)R", -SO 2 R" or SO 3 H, where X' and R" have a meaning indicated above. The heterocyclic group is preferably substituted or non-substituted 2- or 3 30 furyl, 2- or 3-thienyl, 1-, 2- or 3-pyrrolyl, 1-, 2-, 4- or 5-imidazolyl, 3-, 4- or 5-pyrazolyl, 2-, 4- or 5-oxazolyl, 3-, 4- or 5-isoxazolyl, 2-, 4- or 5-thiazolyl, 3-, 4- or 5-isothiazolyl, 2-, 3- or 4-pyridyl, 2-, 4-, 5- or 6-pyrimidinyl, further- WO 2012/163489 PCT/EP2012/002179 -24 more preferably 1,2,3-triazol-1-, -4- or -5-yl, 1,2,4-triazol-1-, -4- or -5-yl, 1 or 5-tetrazolyl, 1,2,3-oxadiazol-4- or -5-yl, 1,2,4-oxadiazol-3- or -5-yl, 1,3,4 thiadiazol-2- or -5-yl, 1,2,4-thiadiazol-3- or -5-yl, 1,2,3-thiadiazol-4- or -5-yl, 2-, 3-, 4-, 5- or 6-2H-thiopyranyl, 2-, 3- or 4-4H-thiopyranyl, 3- or 4-pyridaz 5 inyl, pyrazinyl, 2-, 3-, 4-, 5-, 6- or 7-benzofuryl, 2-, 3-, 4-, 5-, 6- or 7-benzo thienyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-1H-indolyl, 1-, 2-, 4- or 5-benzimidazolyl, 1-, 3-, 4-, 5-, 6- or 7-benzopyrazolyl, 2-, 4-, 5-, 6- or 7-benzoxazolyl, 3-, 4-, 5-, 6- or 7-benzisoxazolyl, 2-, 4-, 5-, 6- or 7-benzothiazolyl, 2-, 4-, 5-, 6- or 7 benzisothiazolyl, 4-, 5-, 6- or 7-benz-2,1,3-oxadiazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 10 7- or 8-quinolinyl, 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolinyl, 1-, 2-, 3-, 4- or 9 carbazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-acridinyl, 3-, 4-, 5-, 6-, 7- or 8 cinnolinyl, 2-, 4-, 5-, 6-, 7- or 8-quinazolinyl or 1-, 2- or 3-pyrrolidinyl. Heteroaryl-C-C 6 -alkyl is, analogously to aryl-C 1
-C
6 -alkyl, taken to mean, for 15 example, pyridinylmethyl, pyridinylethyl, pyridinylpropyl, pyridinylbutyl, pyri dinylpentyl, pyridinylhexyl, where the heterocycles described above may furthermore be linked to the alkylene chain in this way. HetNz+ is preferably 20 pyridinium pyrimidinium imidazolium pyrrolidinium pyrazolium R? R- R1 R47 Rz RN R 2 - R 2
R
2 R R RR R 3 , N , RT R2I ~N ',R, N, I 3 I- \ R4R 7
R
7 N /N\ R 3 ' Rz N' R 4 1 Rz N' R R2'R R" R 4 1 RV R 25 piperidinium indolinium
R
3 ' R2 Ra' R2 Rz Rz R / R -- R3' R1 R 4 or R R 4 30 where the substituents R 1 to R 4 ' each, independently of one another, have a meaning described above.
WO 2012/163489 PCT/EP2012/002179 - 25 HetNz+ is particularly preferably pyridinium imidazolium pyrrolidinium NR N
R
3
R
2 ' : Rz 5- RRR RRr RT + Rz + Rz Rz /N\ + R 3 ' RT , R , R' R 4 ' where the substituents R" to R 4 each, independently of one another, have a meaning described above. 10 HetNz+ is very particularly preferably imidazolium pyrrolidinium RZ R2- R3' R2' 2 R2 RV' 15 R N 4 , R4' R N R21 R1 + Rz /N \+ RV' RT or, R" R 4 ' where the substituents R" to R4' each, independently of one another, have a meaning described above. Preferred meanings of Rr to R4' within imidazolium or pyrrolidinium cations are defined in the following terms: 20 Preferred 1,1-dialkylpyrrolidinium cations are, for example, 1,1-dimethyl pyrrolidinium, 1-methyl-1-ethylpyrrolidinium, 1-methyl-1-propylpyrrolidinium, 1-methyl-1-butylpyrrolidinium, 1-methyl-1-pentylpyrrolidinium, 1-methyl-1 hexylpyrrolidinium, 1-methyl-1-heptylpyrrolidinium, 1-methyl-1-octylpyrroli 25 dinium, 1-methyl-1-nonylpyrrolidinium, 1-methyl-1-decylpyrrolidinium, 1,1 diethylpyrrolidinium, 1-ethyl-1 -propylpyrrolidin ium, 1-ethyl-1 -butylpyrrolidin ium, 1-ethyl-1-pentylpyrrolidinium, 1-ethyl-1 -hexylpyrrolidinium, 1-ethyl-1 heptylpyrrolidinium, 1-ethyl-1 -octylpyrrolidinium, 1-ethyl-1-nonylpyrrolidin ium, 1-ethyl-1 -decylpyrrolidinium, 1,1-dipropylpyrrolidinium, 1-propyl-1 30 methylpyrrolidinium, 1-propyl-1-butylpyrrolidinium, 1-propyl-1-pentylpyrroli dinium, 1-propyl-1-hexylpyrrolidinium, 1-propyl-1-heptylpyrrolidinium, 1- WO 2012/163489 PCT/EP2012/002179 - 26 propyl-1-octylpyrrolidinium, 1-propyl-1-nonylpyrrolidinium, 1-propyl-1-decyl pyrrolidinium, 1,1-dibutylpyrrolidinium, 1-butyl-1-methylpyrrolidinium, 1 butyl-1-pentylpyrrolidinium, 1-butyl-1-hexylpyrrolidinium, 1-butyl-1-heptyl pyrrolidinium, 1-butyl-1-octylpyrrolidinium, 1-butyl-1-nonylpyrrolidinium, 5 1-butyl-1-decylpyrrolidinium, 1,1-dipentylpyrrolidinium, 1-pentyl-1-hexyl pyrrolidinium, 1-pentyl-1-heptylpyrrolidinium, 1-pentyl-1-octylpyrrolidinium, 1-pentyl-1-nonylpyrrolidinium, 1-pentyl-1-decylpyrrolidinium, 1,1-dihexyl pyrrolidinium, 1-hexyl-1-heptylpyrrolidinium, 1-hexyl-1-octylpyrrolidinium, 1-hexyl-1-nonylpyrrolidinium, 1-hexyl-1-decylpyrrolidinium, 1,1-dihexyl 10 pyrrolidinium, 1-hexyl-1-heptylpyrrolidinium, 1-hexyl-1-octylpyrrolidinium, 1-hexyl-1-nonylpyrrolidinium, 1-hexyl-1-decylpyrrolidinium, 1,1-diheptyl pyrrolidinium, 1-heptyl-1-octylpyrrolidinium, 1-heptyl-1-nonylpyrrolidinium, 1-heptyl-1-decylpyrrolidinium, 1,1-dioctylpyrrolidinium, 1-octyl-1-nonyl pyrrolidinium, 1-octyl-1-decylpyrrolidinium, 1,1-dinonylpyrrolidinium, 1 15 nonyl-1-decylpyrrolidinium or 1,1-didecylpyrrolidinium. Very particular preference is given to 1-butyl-1-methylpyrrolidinium or 1-propyl-1-methyl pyrrolidinium. Preferred 1-alkyl-1-alkoxyalkylpyrrolidinium cations are, for example, 1 20 methoxymethyl-1-methyl-pyrrolidinium, 1 -methoxymethyl-1 -ethyl pyrrolidinium, 1-(2-methoxyethyl)-1-methylpyrrolidinium, 1-(2 methoxyethyl)-1-ethylpyrrolidinium, 1-(2-methoxyethyl)-1-propyl pyrrolidinium, 1-(2-methoxyethyl)-1-butylpyrrolidinium, 1-(2-ethoxyethyl)-1 methylpyrrolidinium, 1-ethoxymethyl-1-methylpyrrolidinium, 1-ethoxymethyl 25 1-ethyl-pyrrolidinium. Very particular preference is given to 1-(2 methoxyethyl)-1 -methylpyrrolidinium. Preferred 1,3-dialkylimidazolium cations are, for example, 1 -ethyl-3-methyl imidazolium, 1-methyl-3-propylimidazolium, 1,2,3-trimethylimidazolium, 1 30 ethyl-2,3-dimethylimidazolium, 1-propyl-2,3-dimethylimidazolium, 1-butyl 2,3-dimethylimidazolium, 1-butyl-3-methylimidazolium, 1-methyl-3 pentylimidazolium, 1-ethyl-3-propylimidazolium, 1-butyl-3-ethylimidazolium, WO 2012/163489 PCT/EP2012/002179 -27 1-ethyl-3-pentylimidazolium, 1-butyl-3-propylimidazolium, 1,3-dimethyl imidazolium, 1,3-diethylimidazolium, 1,3-dipropylimidazolium, 1,3 dibutylimidazolium, 1,3-dipentylimidazolium, 1,3-dihexylimidazolium, 1,3-di heptylimidazolium, 1,3-dioctylimidazolium, 1,3-dinonylimidazolium, 1,3 5 didecylimidazolium, 1-hexyl-3-methylimidazolium, 1-heptyl-3-methylimida zolium, 1-methyl-3-octylimidazolium, 1-methyl-3-nonylimidazolium, 1-decyl 3-methylimidazolium, 1-ethyl-3-hexylimidazolium, 1-ethyl-3-heptylimida zolium, 1-ethyl-3-octylimidazolium, 1-ethyl-3-nonylimidazolium or 1-decyl-3 ethylimidazolium. Particularly preferred cations are 1-ethyl-3-methylimida 10 zolium, 1-butyl-3-methylimidazolium or 1-methyl-3-propylimidazolium. Preferred 1-alkoxyalkyl-3-alkylimidazolium cations are, for example 1 methoxymethyl-3-methylimidazolium, 1-methoxymethyl-3-ethylimidazolium, 1-methoxymethyl-3-butylimidazolium, 1-(2-methoxyethyl)-3-methyl 15 imidazolium, 1 -(2-methoxyethyl)-3-ethylimidazolium, 1-(2-methoxyethyl)-3 propylimidazolium, 1-(2-methoxyethyl)-3-butylimidazolium, 1-(2 ethoxyethyl)-3-methylimidazolium, 1-ethoxymethyl-3-methylimidazolium. Preferred 1-alkenyl-3-alkylimidazolium cations are, for example 1-allyl-3 20 methyl-imidazolium or 1-allyl-2,3-dimethylimidazolium. Preferred cations of formula (9) are diphenyliodonium, ditolyliodonium, phenyltolyliodonium, tolyl-(4-sec.-butylphenyl)iodonium, di(p-tert butylphenyl)iodonium, p-methoxyphenyl-phenyliodonium, di(p 25 methoxyphenyl)iodonium, m- or p-CN-phenyl-phenyliodonium, m- or p
(C
6
H
5 S)-phenyl-phenyliodonium. The organic cations of the compounds of formula I according to the invention are preferably sulfonium, ammonium, phosphonium cations of 30 formula (2), (3) and (4) or heterocyclic cations of formula (8), particularly preferably sulfonium cations of formula (2) or heterocyclic cations of WO 2012/163489 PCT/EP2012/002179 - 28 formula (8) as described above, especially for the application as electrolyte component.. The organic cations of the compounds of formula I according to the 5 invention are very particularly preferably heterocyclic cations of formula (8) in which HetNz+ is as defined above, where the substituents R" to R4' each, independently of one another, have a meaning described above for the application as electrolyte component. The organic cation of the compound of formula I is very particularly preferably imidazolium, where the 10 substituents R' to R 4 ' each, independently of one another, have a meaning described above or has one of the particularly preferred meanings of 1,3 dialkylimidazolium, 1-alkenyl-3-alkylimidazolium or 1-alkoxyalkyl-3 alkylimidazolium as described above. 15 Particularly suitable organic cations of the formula I are for this application 1-butyl-1-methylpyrrolidinium, 1-ethyl-3-methylimidazolium, 1-ethyl-2,3 dimethylimidazolium, 1-(2-methoxyethyl)-3-methylimidazolium, 1-butyl-3 methylimidazolium, tributyl-methylammonium, tetra-n-butylammonium, tributyl-methylphosphonium, tetra-phenylphosphonium, diethyl 20 methylsulfonium, S-ethyl-N,N,N',N'-tetramethylisothiouronium, 1-allyl-3 methylimidazolium, 1-allyl-2,3-dimethylimidazolium, 1-cyanomethyl-3 methylimidazolium, 1-methyl-3-propinylimidazlium, 1,1 dimethylpyrrolidinium or trimethylsulfonium. 25 It goes without saying to the person skilled in the art that substituents, such as, for example, C, H, N, 0, Cl, F, in the compounds according to the inven tion may be replaced by the corresponding isotopes. Compounds of formula I in which [Kt]z+ is Li* can be preferably used as 30 conductive salts in primary batteries, secondary batteries, capacitors, supercapacitors or electrochemical cells, optionally also in combination with WO 2012/163489 PCT/EP2012/002179 -29 further conductive salts and/or additives, as constituent of a polymer electrolyte or phase-transfer medium. Compounds of formula I in which [Kt]z+ is Na* or K* can be preferably used 5 as starting materials for compounds of formula I in which [Kt]z+ is an organic cation or another inorganic cation than sodium or potassium. Compounds of formula I in which [Kt]z+ corresponds to formula (2), (5), (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium as described 10 above or preferably described above are preferably used as cationic polymerization initiator, photo-polymerization initiator or photo-acid generator. Particularly preferred organic cations to be used for this technical application corresponds to triarylsulfonium- or diaryliodonium cations in 15 which aryl is defined as described above for the cations of formula (9). Very particularly preferred organic cations to be used for this technical application as cationic polymerization initiator, photo-polymerization initiator or photo-acid generator are triphenylsulfonium, tritolylsulfonium, p-(tert butyl)phenyl-diphenylsulfonium, p-methoxyphenyl-diphenylsulfonium, p 20 C 6
H
13 S-phenyl-diphenylsulfonium, m- or (p-C 6
H
5 S-phenyl) diphenylsulfonium, tri[4-(4-acetyl-phenylsulfanyl)phenyl]sulfonium, tri(4 tert.-butylphenyl)sulfonium, diphenyliodonium, ditolyliodonium, phenyltolyliodonium, di(p-tert-butylphenyl)iodonium, m- or (p-C 6
H
5
S
phenyl)-phenyliodonium or tolyl-(4-sec.-butylphenyl)iodonium. 25 In addition, the invention relates to a process for the preparation of a compound of formula I as described before in which [Kt]z+ is an alkali metal cation and z denotes 1 which denotes a compound of formula I-1 including sodium hydrido-tricyano-borate and potassium hydrido-tricyano-borate, 30 [Me]' [BH(CN) 3 1 I-1 WO 2012/163489 PCT/EP2012/002179 - 30 comprising in step 1 the reaction of a compound of formula 11 [Me 1
]
4
[B(CN)
4 ]~ 11 with an alkali metal [Me], where [Me']* in formula i denotes an alkali metal cation which is different 5 or equal to the alkali metal [Me] resulting in the formation of a compound of formula Ill {[Me]*} 2
[B(CN)
3
]
2 - Il in which [Me]' denotes the alkali metal cation of the alkali metal and comprising in step 2 the hydrolysis of the compound of formula Ill resulted 10 from step 1. Compounds of formula 11 are commercially available e.g. from Merck KGaA, Darmstadt or can be synthesized according to WO 2004/072089, especially as disclosed in examples 1 to 3. 15 Alkali metals are commercially available materials. [Me]" is preferably K' or Na 4 , especially preferably K*. [Me] is preferably lithium, sodium, potassium or their mixtures, especially preferably sodium. 20 The process for the preparation of compounds of the formula I in which [Kt]z+ is an alkali metal cation and z denotes 1 which denotes a compound of formula 1-1 as described above is carried out in liquid ammonia or in organic solvents which are inert to alkali metals, for example tetrahydrofuran, dialkyl ethers or amide-based solvents. If reaction 25 proceeds in organic solvent the application of some catalysts, for example benzophenone, can accelerate the process and improve the yield of compounds of formula Ill. Useful amide solvents are N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone or HMPT (hexamethylphosphortriamide). 30 Liquid ammonia is condensed at temperatures around -78*C and the reaction mixture is warmed up to a temperature between -50*C to -30*C in WO 2012/163489 PCT/EP2012/002179 - 31 the presence of an inert atmosphere, like nitrogen or argon followed by warming up to 100C to 30 0 C and evaporation of ammonia. The hydrolysis of step 2 is preferably carried out in water at temperatures between 150C and 30*C, preferably at room temperature, in the absence or 5 in the presence of an inorganic base such as alkali metal carbonates or acetates, or organic bases, preferably trialkylamines. It is preferable to purify the compounds of formula 1-1 by extraction with an organic solvent. 10 Useful organic solvents are for example, acetonitrile, dimethoxyethane, diglyme, tetrahydrofurane, or methyl-tert-butyl ether. In addition, the invention relates to a special process for the preparation of a compound of formula I as described above in which [Kt]z+ is the cation of 15 potassium and z denotes 1 which denotes a compound of formula 1-2
[K]
4
[BH(CN)
3 ]~ 1-2 comprising the reaction of a compound of formula IV [Me 2 ]+ [BH4]~ IV in which [Me 2 ] + denotes an alkali metal cation 20 with {4 KSCN + K 2 [Zn(SCN) 4 ]} and purification from minor amounts of the optional side product K[BH 2
(CN)
2 ]. The reaction is carried out in a solid state reaction in inert atmosphere (nitrogen or argon) at temperatures between 1000C to 2200C, preferably at 1500C to 2000C, especially preferably at 1850C. 25 After cooling to room temperature, the mixture is dissolved in water and purified according to known methods in the art such as extraction methods. The complex of rhodanid salts can be prepared from commercially available sodium or potassium rhodanid and zinc sulfate. 30 [Me 2 ]+ is preferably K* or Na 4 , especially preferably Na 4 . Sodium and potassium tetrahydridoborate is commercially available.
WO 2012/163489 PCT/EP2012/002179 - 32 In addition, the invention relates to a process for the preparation of a compound of formula I as described above in which [Kt]z+ is an alkali metal cation and z denotes 1 comprising the reaction of a compound of formula II [Me']* [B(CN)4]~ 11 5 with a strong base, preferably an alkali metal hydroxide, an alkali metal amide, a substituted amide or alkali metal alcoholate, where [Me']* in formula I denotes an alkali metal cation which is different or equal to the alkali metal cation of the alkali metal hydroxide, alkali metal amide or alkali metal alcoholate. The alkali metal hydroxide is especially preferably used 10 as strong base in the reaction with compounds of formula 1I. The reaction is carried out without solvent or in the presence of an organic solvent at a temperature between 20 0 C and 2000C, preferably at 500C to 2000C, preferably at 1000 to 160 0 C. 15 Useful organic solvents are for example acetonitrile, dimethoxyethane, diglyme, tetrahydrofurane or methyl-tert-butyl-ether or amide solvents, like N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone or HMPT (hexamethylphosphortriamide). 20 The process for the preparation of compounds of formula I in which the cation is an organic cation or an inorganic cation other than an alkalimetal cation is a metathesis reaction (salt-exchange reaction) in which the cation will be replaced as commonly known. 25 The invention therefore also relates to a process for the preparation of a compound of formula I according to one or more of claims 1 to 3 in which [Kt]z+ is another cation than the used alkali metal cation in the starting material and z is 1, 2, 3 or 4 including sodium hydrido-tricyano-borate, potassium hydrido-tricyano-borate and silver hydrido-tricyano-borate in a 30 salt-exchange reaction, characterized in that an alkali metal salt of formula 1-1 [Me]* [BH(CN) 3 ] 1-1 WO 2012/163489 PCT/EP2012/002179 - 33 in which [Me]+ is an alkali metal cation or H[BH(CN) 3 ] is reacted with a compound of formula V KtA V, in which 5 Kt has a meaning of an organic cation or inorganic cation other than the alkali metal cation of the compound of formula 1-1 or H' and A denotes F-, Cl-, Br-, I-, OH-, [HF 2 ] , [CN]-, [SCN]-, [R1COO]-, [RIOC(0)O]~, [R 1 S0 3 ] , [R2COO]-, [R 2
SO
3 ]~, [R 1 0S0 3 ]~, [PF 6 ]-, [BF 4 ]-,
[HSO
4 ] 1-, [SO 4 ] 2-, [N0 3 ] , [(R 2
)
2 P(O)O]-, [R 2 P(O)0 2
]
2 -, [(R10)2P(O)O]~, 10 [(R 1 0)P(0)0 2
]
2 -, [(RO)R 1 P(O)O]~, tosylate, malonate which may be substituted by straight-chain or branched alkyl groups having 1 to 4 C atoms, [HOCO 2 ] or [CO 3 ] 2-, with the proviso that [SO 4 ] 2- and [C03] 2- are used merely for the synthesis of compounds of formula I having another metal cation than the alkali metal cation of the compound of formula I-1, 15 in which R 1 is each independently of another a straight-chain or branched alkyl group having 1 to 12 C atoms and
R
2 is each independently of one another a straight-chain or branched perfluorinated alkyl group having 1 to 12 C atoms and where electroneutrality should be taken into consideration in the formula of the salt 20 KtA.
R
2 is particularly preferred trifluoromethyl, pentafluoroethyl or nonafluorobutyl, very particularly preferred trifluoromethyl or pentafluoroethyl. 25
R
1 is particularly preferred methyl, ethyl, n-butyl, n-hexyl or n-octyl, very particularly preferred methyl or ethyl. Compounds of formula 1-1, as described above, are preferably used in the 30 metathesis reaction as described above. Substituted malonates are for example methyl malonate or ethyl malonate.
WO 2012/163489 PCT/EP2012/002179 - 34 The compounds of formula V are in most cases commercially available or can be synthesised by known processes. Known processes for the preparation of of compounds of formula V are described, for example, in P. 5 Wasserscheid, T. Welton (Eds.), Ionic Liquids in Synthesis, Second Edition, WILEY-VCH, Weinheim, 2008. The anion in the formula V is preferably OH-, Cl~, Br-, I-, [HF 2 ]~, [CN]-, [SCN] -, [CH 3 0C(O)OI -, [CH 3 C(O)O] -, [CH 3
SO
3 ] -, [CF 3 C(O)O] -, 10 [CF 3
SO
3 ] , [CH 3 0SO31 -, [SiF 6 ] 2-, [PF6]~, [BF 4 ] -, [HS0 4 ] 1-, [NO 3 ] ,
[C
2
H
5 OSO3]-, [(C 2
F)
2 P(O)O]-, [C 2
F
5 P(O)02]2-, tosylates, malonates or
[SO
4 ] 2- and [C03] 2- with the proviso that [S04] 2- and [C03] 2~ are used merely for the synthesis of compounds of formula I having another metal cation than the alkali metal cation of the compound of formula I-1, 15 particularly preferably OH-, Cl-, Br~, I-, [CH 3
SO
3 ]~, [CH 3 0SO 3 ] , [PF 6 ]-,
[CF
3 COO]-, [CF 3
SO
3 ] , [(C 2
F
5
)
2 P(O)O]- or [C0 3
]
2 -. The anion in the formula V is very particularly preferably OH-, Cl -, Br-,
[CH
3 0SO 3 ]~, [CF 3
SO
3 ] -, [CH 3
SO
3 ] - for the synthesis of compounds of 20 formula I having an inorganic cation and the anion in the formula V is very particularly preferably OH-, Cl-, Br-, [CH 3 0SO 3 ]-, [PF 6 ]-, [CF 3
SO
3 ] -,
[CH
3
SO
3 ] - or [(C 2
F)
2 P(O)O- for the synthesis of compounds of formula I having an organic cation. 25 Suitable organic salts for the preparation of the compounds of the formula I in which [Kt]z+ is an organic cation are salts with cations of formula (1) to (8) or their preferred embodiments together with anions as defined as A described above or its preferred embodiments which means salts of cations of formulae (1) to (8) or their preferred embodiments and OH-, Cl-, Br-, 30 [CH 3 0SO3]~, [PF6]-, [CF 3 SO31 -, [CH 3
SO
3 ] - or [(C 2
F
5
)
2
P(O)O]-.
WO 2012/163489 PCT/EP2012/002179 - 35 Suitable substance for the preparation of the compound of the formula I in which [Kt]z+ is H* are aqueous H[BF 4 ] and H[PF 6 ] or H[BF 4 ] and H[PF] in organic solvents, preferably in diethylether. Rection of K[BH(CN) 3 ] or Na[BH(CN) 3 ] with H[BF 4 ] or H[PF 6 ] results in the formation of H[BH(CN) 3 ] in 5 solvated form and purely soluble potassium or sodium hexafluorophosphate or tetrafluoroborate. Suitable inorganic salts for the preparation of the compounds of the formula I in which [Kt]z+ is a metal cation e.g. from the group silver, magnesium, 10 copper, zinc and calcium are, for example, Ag 2 0, Ag 2
CO
3 , MgCO 3 , CuO, ZnO, Zn[HC0 3 1 2 , CaCO 3 or Ca(OC(O)CH 3
)
2 . Useful salts for metathesis reaction to another alkali metal salt of formula I than potassium are e.g. LiBF 4 . 15 The reaction is advantageously carried out in water in the case of the compounds of formula 1-1 or in organic solvent, where temperatures of 100 100 0 C, preferably 15 0 -60 0 C, particularly preferably room temperature, are suitable. 20 However, the reaction can alternatively also be carried out for the compounds of formula I in organic solvents at temperatures between 100 and 100"C. Suitable solvents here are acetonitrile, dialkylethers, tetrahydrofurane, dioxane, dichloromethane, dimethoxyethane or an alcohol, for example methanol, ethanol or iso-propanol. 25 The present invention furthermore relates to compounds of formula Ill {[Me]*}2 [B(CN) 3
]
2 - l1l in which [Me]+ denotes an alkali metal cation, which is preferably Li*, Na* or K*. 30 The present invention furthermore relates to the corresponding process for the preparation of a compound of formula Ill as described above comprising WO 2012/163489 PCT/EP2012/002179 - 36 the reaction of a compound of formula I [Me']+ [B(CN)4 II in which [Me']+ denotes an alkali metal cation with an alkali metal [Me'] in which the alkali metal [Me'] and the alkali metal cation [Me']+ are the same 5 or different The reaction above is carried out in liquid ammonia or in organic solvents which are inert to alkali metals, for example tetrahydrofuran, dialkyl ethers or amide-based solvents. Liquid ammonia is condensed at temperatures around -78 0 C and the reaction mixture is warmed up to a temperature 10 between -50*C to -300C in the presence of an inert atmosphere, like nitrogen or argon followed by warming up to 10*C to 300C and evaporation of ammonia. The salts Na 2
[B(CN)
3 ], Li2[B(CN) 3 ] and K2[B(CN) 3 ] are very moisture 15 sensitive compounds, but they can be stored in the glove-box for a long time. These salts are soluble in liquid ammonia, dimethylformamide, slightly soluble in acetonitrile and NH 2
CH
2
CH
2
NH
2 . They are insoluble in tetrahydrofuran and diethylcarbonate. 20 The invention furthermore relates to the use of compounds of formula Ill as described above for the introduction of B(CN)3-groups in chemical substances via reaction with electrophiles. The present invention furthermore relates to the use of the compounds of 25 formula I as described above as media for chemical reactions, as catalyst and/or as media in catalytical processes, as conducting salts, as components of electrolytes for the application in electrochemical cells, as components of supporting electrolytes for electrochemical processes, as surfactants, as phase-transfer catalysts, as trainer, as extractant; as 30 antistatic additive, as plasticiser; as heat-transfer-medium, as modifier for membranes and textile materials; as lubricant, as additive to lubricant WO 2012/163489 PCT/EP2012/002179 - 37 compositions or to another engineering fluids; as hydraulic fluid or as additive to hydraulic fluids. Preferably, compounds of formula I having inorganic cations as described 5 above are useful as catalyst, as conducting salts, as components of electrolytes for the application in electrochemical cells, as components of supporting electrolytes for electrochemical processes, as surfactants, as phase-transfer catalysts or as antistatic additive. 10 Preferably, compounds of formula I having organic cations as described above or H* are useful as media for chemical reactions, as catalyst and/or as media in catalytical processes, as conducting salts, as components of electrolytes for the application in electrochemical cells, as components of supporting electrolytes for electrochemical processes, as surfactants, as 15 phase-transfer catalysts, as trainer, as extractant; as antistatic additive, as plasticiser; as heat-transfer-medium, as modifier for membranes and textile materials; as lubricant, as additive to lubricant compositions or to another engineering fluids; as hydraulic fluid or as additive to hydraulic fluids. 20 In the case of the use of the said organic salts of formula I as media in catalytical processes or as solvents, these are suitable in any type of reaction known to the person skilled in the art, for example for transition metal- or enzyme-catalysed reactions, such as, for example, hydroformylation reactions, oligomerisation reactions, esterifications or 25 isomerisations, where the said list is not exhaustive. On use as extractant, the organic salts of formula I can be employed to separate off reaction products, but also to separate off impurities, depending on the solubility of the respective component in the ionic liquid. 30 In addition, the ionic liquids may also serve as separation media in the separation of a plurality of components, for example in the distillative separation of a plurality of components of a mixture.
WO 2012/163489 PCT/EP2012/002179 - 38 Further possible applications are use as plasticiser in polymer materials and as conductive salt or additive in various electrochemical cells and applications, for example in galvanic cells, in capacitors or in fuel cells. 5 Further fields of applications of the organic salts of formula 1, according to this invention are solvents for carbohydrate containing solids in particular biopolymers and derivatives or degredation products thereof. In addition, these new compounds can be applied as lubricants, working fluids for 10 maschines, such as compressors, pumps or hydraulic devices. A further field of application is the field of particle or nanomaterial synthesis where these ionic liquids can act as medium or additive. The compounds of formula I in which [Kt]z+ corresponds to formula (2), (5), 15 (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium as described above or preferably described above are preferably used as cationic polymerization initiator, photo-polymerization initiator or photo-acid generator. 20 A cationic polymerization initiator is able to start the polymerization of at least one monomer, for example the polymerization of cationic polymerizable compounds such as iso-butylene, styrene, vinylethers, lactones, lactames, cyclic ethers or epoxy-containing compounds. 25 The process of polymerization is started via radiation in case a photo polymerization initiator is used which means that the mixture of photo initiator and at least one monomer is irradiated through energetic rays such as light, electrons or gamma rays. This kind of photo-polymerization normally leads especially to quickly crosslinked end products. The 30 compounds of formula I with cations of formula (2), (5), (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium as described above are WO 2012/163489 PCT/EP2012/002179 - 39 cationic photo-polymerization initiators. Particularly, compounds of formula I with cations of formula (2) and (9) are preferred. Photo-polymerization initiators are often components of formulations of 5 lacquers or resins which often need a curing in fractional amounts of seconds. The curing may be inititated through light, laser, electrons or gamma rays, especially through UV-Iight. Photo-polymerization is often used in various technical applications for 10 example for curing a coating film, forming a planographic printing plate, a resin letterpress printing plate and a printed circuit board, preparing a photoresist and a photomask, and making a black-and-white or color transfer sheet and a coloring sheet. 15 In case the compounds of formula I with cations of formula (2), (5), (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium are irradiated with light, laser, electrons or gamma rays, they are able to build the corresponding Bronsted acid or Lewis acid on spot which means in a catalytic amount and are therefore able to start the polymerization through 20 this acid. Such compounds which show such a property are commonly known as photo-acid generator (PAG). PAG's are highly active and have been shown to catalyze the deprotection of acid-sensitive organic functional groups with good photospeeds. PAG's are very often used in resists. 25 Another object of the invention is therefore a curable composition comprising at least one compound of formula I with cations of formula (2), (5), (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium as described before and at least one polymerizable compound. 30 Another object of the invention is therefore a curable composition comprising at least one compound of formula I with cations of formula (2) WO 2012/163489 PCT/EP2012/002179 -40 and (9) as described or preferably described before and at least one polymerizable compound. The compounds of formula I with organic cations, e.g. ionic liquids 5 according to this invention may be preferably used in electrochemical and/or optoelectronic devices, especially in electrolyte formulations. The present invention therefore relates furthermore to an electrolyte formulation comprising at least one compound of formula I as described 10 above or preferably described. Electrolyte formulations comprising compounds of formula I in which [Kt]" is an organic cation can be preferably used in electrochemical cells, optionally also in combination with further conductive salts and/or additives, 15 as constituent of a polymer electrolyte or phase-transfer medium. Electrolyte formulations comprising compounds of formula I can be preferably used in electrochemical and/or optoelectronic devices such as a photovoltaic cell, a light emitting device, an electrochromic or photo 20 electrochromic device, an electrochemical sensor and/or biosensor, particularly preferred in a dye sensitised solar cell. Such electrolyte formulations form a crucial part of the disclosed devices and the performance of the device largely depends on the physical and 25 chemical properties of the various components of these electrolytes. Factors which are still impeding the technical application of many electrochemical and/or optoelectronic devices and in particular of dye or quantum dot sensitized solar cells, are reliability problems caused by the 30 volatility of organic solvents based electrolytes. It is very difficult to maintain a tight sealing of the electrolyte in e.g. a DSC panel, which has to withstand the temperature differences of daily day-night cycles and the concomitant WO 2012/163489 PCT/EP2012/002179 -41 thermal expansion of the electrolyte. The abbreviation DSC means dye sensitized solar cell. This problem can be solved in principle by the use of ionic liquid-based electrolytes. For review "Ionic liquid electrolytes for dye sensitized solar cells" see: William R Pitner et al., "Application of Ionic 5 Liquids in Electrolyte System" Green Chemistry. vol.6, (2010). Ionic liquids or liquid salts are typically ionic species which consist of an organic cation and a generally inorganic anion usually having melting points below 373 K. Various binary ionic liquid electrolytes have recently been applied to dye-sensitized solar cells. WO 2007/093961 and WO 10 2009/083901 describe so far the best power conversion efficiencies in ionic liquid-based electrolytes for DSC containing a significant quantity of organic salts with tetracyanoborate (TCB) anions. Electrolyte formulations according to the invention are alternatives to 15 already known electrolyte formulations. They show especially in the field of electrolyte formulations of dye sensitised solar cells a good performance particularly under high temperature. The advantage of the use of compounds of formula I having an organic cation and a hydrido-tricyano borate anion is their low viscosity and high thermal stability. 20 In chemistry, an electrolyte is any substance containing free ions that make the substance electrically conductive. The most typical electrolyte is an ionic solution, but molten electrolytes and solid electrolytes are also possible. 25 An electrolyte formulation according to the invention is therefore an electrically conductive medium, basically due to the presence of at least one substance that is present in a dissolved and or in molten state and undergo dissociation into ionic species, i.e. supporting an electric conductivity via motion of ionic species. However, the said electric 30 conductivity may not be of the major relevance to the role of the electrolyte of a dye-sensitised solar cell. Therefore, the scope of this invention is not limited to highly conductive electrolyte media.
WO 2012/163489 PCT/EP2012/002179 -42 The term electrolyte may be used for the term electrolyte formulation as well comprising all ingredients as disclosed for the electrolyte formulation. 5 The electrolyte formulations according to the invention may include or comprise, essentially consist of or consist of the said necessary or optional constituents. All compounds or components which can be used in the agents or compositions are either known and commercially available or can be synthesized by known processes. 10 Typical molar concentrations of the hydridotricyanoborate compound in the electrolyte formulations range from 0.1 to 5.5 M, preferably from 0.8 to 3.5 M. This molar concentration in the electrolyte may be achieved with one or more compounds of formula I in which Kt" has a meaning as described or 15 preferably described above. Preferably, the molar concentration is achieved with at least one compound of formula I as described or preferably described above. For the purpose of the present invention, the molar concentration refer to 20 the concentration at 25*C. The present invention relates furthermore to an electrolyte formulation comprising at least one compound of formula (1) as described above or preferably described together with redox active species such as iodide/tri 25 iodide, Ferrocene derivatives or Co(ll)/Co(Ill) complexe couples such as Co(ll)/Co(lll)(dbbip) 2 in which dbbip means 2,6-bis(1'-butylbenzimidazol-2' yl)pyridine, Co(ll)/Co(ill)(bpy) 3 where bpy denotes bipyridine or alkylated bipyridine derivates thereof, Co(ll)/Co(lll)(dmb) 3 where dmb denotes 4,4' dimethyl-2,2'-bipyridine, Co(ll)/Co(Ill)(dtb) 3 where dtb denotes 4,4'-di-tert 30 butyl-2,2'-bipyridine, Co(II)/Co(Ill)(phen) 3 where phen denotes 1,10 phenanthroline, preferably a redox couple of iodine and at least one iodide salt.
WO 2012/163489 PCT/EP2012/002179 -43 The electrolyte formulation of the invention preferably comprises iodine (12). Preferably, it comprises from 0.0005 to 7 mol/dm 3 , more preferably 0.01 to 5 mol/dm 3 and most preferably from 0.05 to 1 mol/dm 3 of 12. 5 The iodide salt consists of an inorganic or organic cation and I- as anion. There exists no limitation to the kind of cation. However, to limit the amount of different cations in the electrolyte formulations, especially for DSC, organic cations shall be used as already described for the compounds of 10 formula 1. Preferably, the electrolyte formulation comprises at least one iodide salt in which the organic cation is independently selected from the group of imidazolium pyrrolidinium Rr Rz R3' R 2 ' 15 2 R'N ZN R 4 R N R' Rz or, Rr R 4 ' in which the substituents
R
2 and R 3 each, independently of one another, denote H or straight-chain 20 or branched alkyl having 1 to 20 C atoms, R" and R 4 each, independently of one another, denote straight-chain or branched alkyl having 1-20 C atoms, which optionally may be partially fluorinated or perfluorinated, straight-chain or branched alkenyl having 2-20 C atoms and one or more 25 double bonds, which optionally may be partially fluorinated, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, which optionally may be partially fluorinated. Particularly preferred examples of the at least one iodide salt are 1-ethyl-3 30 methylimidazolium iodide (emim 1), 1-propyl-3-methylimidazolium iodide (pmim I), 1-butyl-3-methyl-imidazolium iodide (bmim I), 1-hexyl-3 methylimidazolium iodide (hmim I), 1,3-dimethyl-imidazolium iodide (mmim WO 2012/163489 PCT/EP2012/002179 -44 1), 1-allyl-3-methylimidazolium iodide (amim 1), N-butyl-N-methyl pyrrolidinium iodide (bmpi 1) or N,N-dimethyl-pyrrolidinium iodide (mmpl 1). Other components of the electrolyte formulation are one or several further 5 salts, solvents, and others, as indicated further below. If the electrolyte formulation is a binary system, it comprises two salts, one further salt or iodide salt and a compound of formula I as described above. If the electrolyte formulation is a ternary system, it comprises two further 10 salts and/or iodide salts and a compound of formula I as described above. The binary system comprises 90-10 weight %, preferably 70-30 weight %, more preferably 55-40 weight % of the further salt or iodide salt and 10-90 weight %, preferably 30-70 weight % or more preferably 45-60 weight % of the compound of formula I as described above. The percentages in this 15 paragraph are expressed with respect to the total of salts (= 100 weight %) present in the electrolyte formulation according to the invention. Amounts of further, generally optional components (additives) indicated below, such as N-containing compounds having unshared electron pairs, iodine, solvents, polymers, and nanoparticles, for example, are not considered therein. The 20 same percentages apply to ternary or quaternary systems which means the total of the further salts has to be used in the given ranges, e.g. two further ionic liquids are comprised in e.g. 90-10. weight.% in the electrolyte formulation according to the invention. 25 According to another embodiment of the present invention, the electrolyte formulation comprises at least one further salt with organic cations comprising a quaternary nitrogen and an anion selected from a halide ion, such as F, Cr, a polyhalide ion, a fluoroalkanesulfonate, a fluoroalkanecarboxylate, a tris(fluoroalkylsulfonyl)methide, a 30 bis(fluoroalkylsulfonyl)imide, bis(fluorosulfonyl)imide, a nitrate, a hexafluorophosphate, a tris- , bis- and mono-(fluoroalkyl)fluorophosphate, a tetrafluoroborate, a dicyanamide, a tricyanomethide, a tetracyanoborate, a WO 2012/163489 PCT/EP2012/002179 -45 thiocyanate, an alkylsulfonate or an alkylsulfate, with fluoroalkane-chain having 1 to 20 C atoms, preferably perfluorinated, fluoroalkyl having 1 to 20 C atoms and alkyl having 1 to 20 C atoms. Fluoroalkane-chain or fluoroalkyl is preferably perfluorinated. 5 Preferably, the further salts are selected from salts comprising anions such as thiocyanate, tetracyanoborate and/or bis(fluorosulfonyl)imide, particularly preferred further salts are tetracyanoborates. 10 The cation of the at least one further salt or of a preferred further salt may be selected amongst organic cations as defined above for the compounds of formula I including also the preferred meanings. In another embodiment of the invention, guanidinium thiocyanate may be 15 added to the electrolyte formulation according to the invention. In a preferred embodiment, the electrolyte formulation of the present invention further comprises at least one compound containing a nitrogen atom having non-shared electron pairs. Examples of such compounds are 20 found in EP 0 986 079 A2, starting on page 2, lines 40-55, and again from page 3, lines 14 extending to page 7, line 54, which are expressly incorporated herein by reference. Preferred examples of compounds having non-shared electron pairs include imidazole and its derivatives, particularly benzimidazole and its derivatives. 25 The electrolyte formulation of the present invention may comprise an organic solvent. Preferably, the electrolyte formulation comprises the compound comprising a hydridotricyanoborate anion in the range between 5% to 70% and the organic solvent in the range between 70 % to 0 % 30 based on the total weight of the formulation. Particularly preferably, the electrolyte formulation comprises less than 50 % of an organic solvent or less than 40%, more preferably less than 30%, still more preferably less WO 2012/163489 PCT/EP2012/002179 -46 than 20% and even less than 10 %. Most preferably, the electrolyte formulation comprises less than 5% of an organic solvent. For example, it is substantially free of an organic solvent. Percentages are indicated on the basis of weight %. 5 Organic solvents, if present in such amounts as indicated above, may be selected from those disclosed in the literature. Preferably, the solvent, if present, has a boiling point higher than 160 degrees centigrade, more preferably higher than 190 degrees such as propylene carbonate, ethylene 10 carbonate, butylene carbonate, gamma-butyrolactone, gamma valerolactone, glutaronitrile, adiponitrile, N-methyloxazolidinone, N methylpyrrolidinone, N,N'-dimethylimidazolidinone, N,N-dimethylacetamide, cyclic ureas preferably 1,3-dimethyl-2-imidazolidinone or 1,3-dimethyl 3,4,5,6-tetrahydro-2(1 H)-pyrimidinone, glymes preferably tetraglyme, 15 sulfolane, sulfones which are preferably asymmetrically substituted such as 2-ethanesulfonyl-propane, 1-ethanesulfonyl-2-methyl-propane or 2 (propane-2-sulfonyl)-butane, 3-methylsulfolane, dimethylsulfoxide, trimethylphosphate and methoxy-substituted nitriles. Other useful solvents are acetonitrile, benzonitrile and or valeronitrile. Preferred organic solvents 20 are gamma-butyrolactone and tetraglyme. If a solvent is present in the electrolyte formulation, there may further be comprised a polymer as gelling agent, wherein the polymer is polyvinylidenefluoride, polyvinylidene-hexafluropropylene, polyvinylidene 25 hexafluoropropylene-chlorotrifluoroethylene copolymers, nafion, polyethylene oxide, polymethylmethacrylate, polyacrylonitrile, polypropylene, polystyrene, polybutadiene, polyethyleneglycol, polyvinylpyrrolidone, polyaniline, polypyrrole, polythiophene. The purpose of adding these polymers to electrolyte formulations is to make liquid 30 electrolytes into quasi-solid or solid electrolytes, thus improving solvent retention, especially during aging.
WO 2012/163489 PCT/EP2012/002179 -47 The electrolyte formulation of the invention may further comprise metal oxide nanoparticles like SiO 2 , TiO 2 , Al 2 0 3 , MgO or ZnO, for example, which are also capable of increasing solidity and thus solvent retention. 5 The electrolyte formulation of the invention has many applications. For example, it may be used in an optoelectronic and/or electrochemical device such as a photovoltaic cell, a light emitting device, an electrochromic or photo-electrochromic device, an electrochemical sensor and/or biosensor. 10 The present invention therefore relates further to the use of the electrolyte formulation as described in detail above in an electrochemical and/or optoelectronic device which is a photovoltaic cell, a light emitting device, an electrochromic or photo-electrochromic device, an electrochemical sensor and/or biosensor. Preferably, the electrolyte formulation may be used in dye 15 sensitized solar cells. The present invention therefore relates furthermore to an electrochemical and/or optoelectronic device which is a photovoltaic cell, a light emitting device, an electrochromic or photo-electrochromic device, an 20 electrochemical sensor and/or biosensor comprising an electrolyte formulation comprising at least one compound of formula I as described or preferably described above. Preferably, the compound of formula I is a compound of formula I in which 25 [Kt]" is an organic cation as described above including all preferred meanings for application in dye-sensitized solar cells. According to a preferred embodiment, the device of the present invention is a dye or quantum dot sensitized solar cell, particularly preferably a dye 30 sensitized solar cell.
WO 2012/163489 PCT/EP2012/002179 - 48 Quantum dot sensitized solar cells are disclosed in US 6,861,722, for example. In dye -sensitized solar cells, a dye is used to absorb the sunlight to convert into the electrical energy. There are no restrictions per se with respect to the choice of the dye as long as the LUMO energy state is 5 marginally above the conduction bandedge of the photoelectrode to be sensitized. Examples of dyes are disclosed in EP 0 986 079 A2, EP 1 180 774 A2 or EP 1 507 307 Al. Preferred dyes are organic dyes such as MK-1, MK-2 or MK-3 (its 10 structures are described in figure 1 of N. Koumura et al, J.Am.Chem.Soc. Vol 128, no.44, 2006,14256-14257), D102 (CAS no. 652145-28-3), D-149 (CAS no. 786643-20-7), D205 (CAS no. 936336-21-9), D358 (CAS no. 1207638-53-6), YD-2 as described in T. Bessho et al, Angew. Chem. Int. Ed. Vol 49, 37, 6646-6649, 2010, Y123 (CAS no. 1312465-92-1), bipyridin 15 Ruthenium dyes such as N3 (CAS no. 141460-19-7), N719 (CAS no. 207347-46-4), Z907 (CAS no. 502693-09-6), C101 (CAS no. 1048964-93 7), C106 (CAS no. 1152310-69-4), K19 (CAS no. 847665-45-6), HRS-1 (CAS no. 906061-30-1 as disclosed in K.J. Jiang et al, Chem. Comm. 2460, 2006) or terpyridine-Ruthenium dyes such as N749 (CAS no. 359415-47-7). 20 The structure of D205 is 25 N 0 3S 0 30 0 \--COOH WO 2012/163489 PCT/EP2012/002179 -49 The structure of D358 is
(CH
2
)
1 ,-COOH 0 N )~S 5 S N "COOH N 10 15 Particularly preferred dyes are Z907 or Z907Na which are both an amphiphilic ruthenium sensitizer, C106, D358 or HRS-1. The dye Z907Na means NaRu(2,2'-bipyridine-4-carboxylic acid-4'-carboxylate)(4,4'-dinonyl 2,2'-bipyridine)(NCS) 2 . 20 Very particularly preferred dyes are Z907 or Z907Na and/or D358. Very very particularly preferred dyes are Z907 or Z907Na. In a special embodiment, the dye is coadsorbed with a phosphinic acid. A 25 preferred example of a phosphinic acid is bis(3,3-dimethyl-butyl)-phosphinic acid (DINHOP) as disclosed in M. Wang et al, Dalton Trans., 2009, 10015 10020. For example, a dye-sensitized solar cell comprises a photo-electrode, a 30 counter electrode and, between the photo-electrode and the counter electrode, an electrolyte formulation or a charge transporting material, and WO 2012/163489 PCT/EP2012/002179 - 50 wherein a sensitizing dye is absorbed on the surface of the photo-electrode, on the side facing the counter electrode. According to a preferred embodiment of the device according to the 5 invention, it comprises a semiconductor, the electrolyte formulation as described above and a counter electrode. According to a preferred embodiment of the invention, the semiconductor is based on material selected from the group of Si, TiO 2 , Sn0 2 , Fe 2
O
3 , W0 3 , ZnO, Nb 2 0 5 , CdS, ZnS, PbS, Bi 2
S
3 , CdSe, GaP, InP, GaAs, CdTe, CuInS 2 , 10 and/or CuInSe 2 . Preferably, the semiconductor comprises a mesoporous surface, thus increasing the surface optionally covered by a dye and being in contact with the electrolyte. Preferably, the semiconductor is present on a glass support or plastic or metal foil. Preferably, the support is conductive. 15 The device of the present invention preferably comprises a counter electrode. For example, fluorine doped tin oxide or tin doped indium oxide on glass (FTO- or ITO-glass, respectively) coated with Pt, carbon of preferably conductive allotropes, polyaniline or poly (3,4 ehtylenedioxythiophene) (PEDOT). Metal substrates such as stainless steel 20 or titanium sheet may be possible substrates beside glass. The device of the present invention may be manufactured as the corresponding device of the prior art by simply replacing the electrolyte by the electrolyte formulation of the present invention. For example, in the 25 case of dye-sensitized solar cells, device assembly is disclosed in numerous patent literature, for example WO 91/16719 (examples 34 and 35), but also scientific literature, for example in Barbe, C.J., Arendse, F., Comte, P., Jirousek, M., Lenzmann, F., Shklover, V., Gratzel, M. J. Am. Ceram. Soc. 1997, 80, 3157; and Wang, P., Zakeeruddin, S. M., Comte, P., 30 Charvet, R., Humphry-Baker, R., Grstzel, M. J. Phys. Chem. B 2003, 107, 14336.
WO 2012/163489 PCT/EP2012/002179 - 51 Preferably, the sensitized semi-conducting material serves as a photo anode. Preferably, the counter electrode is a cathode. The present invention provides a method for preparing a photoelectric cell 5 comprising the step of bringing the electrolyte formulation of the invention in contact with a surface of a semiconductor, said surface optionally being coated with a sensitizer. Preferably, the semiconductor is selected from the materials given above, and the sensitizer is preferably selected from quantum dots and/or a dye as disclosed above, particularly preferably 10 selected from a dye. Preferably, the electrolyte formulation may simply be poured on the semiconductor. Preferably, it is applied to the otherwise completed device already comprising a counter electrode by creating a vacuum in the internal 15 lumen of the cell through a hole in the counter electrode and adding the electrolyte formulation as disclosed in the reference of Wang et al., J. Phys. Chem. B 2003, 107,14336. The present invention will now be illustrated, without limiting its scope, by 20 way of the following examples. Even without further comments, it is assumed that a person skilled in the art will be able to utilise the above description in the broadest scope. The preferred embodiments and examples should therefore merely be regarded as descriptive disclosure which is absolutely not limiting in any way. 25 The substances are characterised by means of Raman and NMR spectroscopy and X-Ray analysis. The NMR-spectra are measured in deuterated solvents Aceton-D 6 or CD 3 CN by use of Bruker Avance IlIl Spektrometer with Deuterium Lock. The resonance frequency for different 30 nuclea are: 'H: 400,17 MHz, "B: 128,39 MHz, 31 P: 161,99 MHz und I 3 C: 100,61 MHz. The following references are used: TMS fur 'H und 1 3 C spectra and BF 3 -Et 2 O - for 1B spectra.
WO 2012/163489 PCT/EP2012/002179 -52 Examples: Example 1: Potassium hydrido-tricyano-borate - K[BH(CN) 3 ] 2 Na[BH 4 ] + 3 {4KSCN + K 2 [Zn(SCN) 4 } - 5 2 K[BH(CN) 3 1 + 3 ZnS + 3 H 2 S + 2 NaSCN + 16 KSCN The mixture of 1.08 g (28.5 mmol) NaBH 4 and 27 g (3.04 mol) {4KSCN +
K
2 [Zn(SCN) 4 ]} is heated for 5 hours at 185 0C under vacuum. After cooling to room temperature, the reaction mixture is dissolved in 200 cm 3 water and 10 the precipitate of ZnS is filtered off. The solution is treated with 100 cm 3 of 36%-ige HCI and water is distilled of in vacuum at 50-60 *C. The residue is extracted with 250 cm 3 of tetrahydrofuran and non-soluble precipitant is filtered off. The solvent is evaporated in vacuum and residue is dissolved in 100 cm 3 of water. After filtration and treatment with 50 cm 3 of 36%-ige HCI, 15 the solution is evaporated in vacuum at 50-60 *C. The residue is dissolved in 150 cm 3 of acetonitrile. The solution is filtered and evaporated in vacuum. The residue is dissolved in 50 cm 3 of 36%-ige HCl. The solution is left stirring for 12 hours and is evaporated in vacuum at 50-60 *C. The residue is dissolved in 10 cm 3 of water. The solution is neutralized with 20 K 2
CO
3 and filtered. The product is extracted from this solution with tetrahydrofuran (50 +20 + 20 cm 3 ). The THF solution is dried with K 2 CO3 and evaporated. The residue is dried in vacuum. 0.43 g of K[BH(CN) 3 ] is obtained. The product contains of about 10-15% K[BH 2
(CN)
2 ]. Further purification can be achieved by treatment with 36%-ige HCI within 25 15 hours at 100 0C followed by extraction with acetonitrile.
K[BH(CN)
3 ]: a=4.0558(3), b=8.6645(5), c=9.3318(8) A, a=104.127(7), P=100.542( 7 ), = 9 0.110(5) *, V=312.27, Z = 2, P-1, t=150K. Example 2: Potassium hydrido-tricyano-borate - K[BH(CN) 3 1 30 K[B(CN) 4 ] + 2 Na : Na 2
[B(CN)
3 ] + KCN WO 2012/163489 PCT/EP2012/002179 - 53 THF 2 Na 2
[B(CN)
3 1 + 2 H 2 0 + K 2 CO3 IM2 K[BH(CN) 3 ]+ Na 2
CO
3 +2 NaOH To 21.0 g (136 mmol) K[B(CN) 4 ] and 6.3 g (274 mmol) of Na ca. 100 cm 3 of liquid ammonia is condensed by cooling of the reaction vessel with dry ice 5 (- 78 *C). The reaction mixture is slowly warmed up to -40 to -30 *C (temperature in the cooling bath) until the exothermic reaction starts. The reaction mixture formed two phases: upper layer had deep-blue colour of the Na solution in NH 3 ; bottom layer had red-orange colour of Na 2
[B(CN)
3 ] in NH 3 . Within 30-50 min the deep-blue colour practically completely 10 disappeared. This indicated that reaction is completed. The reaction mixture is slowly warmed up in inert atmosphere (Ar) to the room temperature resulting in ammonia evaporation. The residue is pumped for ca. 10 min in vacuum (to remove the traces of ammonia) and treated with 100 cm 3 of water. Within ca. 30 min at room temperature (if the traces of 15 non-reacted Na is remained in the reaction mixture, the cooling of the reaction vessel is recommended) the yellow colour of solid Na 2
[B(CN)
3 ] disappeared and transparent colour-less solution in water is formed. The volume of the reaction mixture is reduced to 40-50 cm 3 . The residue is treated with 22 g K 2
CO
3 and 100 cm 3 of tetrahydrofurane (THF). The THF 20 phase is separated and the water phase is extracted two times with 50 cm 3 of tetrahydrofurane. The combined THF-solution is dried with K 2
CO
3 , filtrated and the sovent is evaporated. The residue is washed with CH 2
CI
2 (2 x 50 cm 3 ) and dried in vacuum. The yield of K[BH(CN) 3 ] is 17.6 g (100%). 25 11 B-NMR: 6, ppm = -40.2 d, 'JB,H = 98 Hz. 1 H{"B}-NMR (Solvent: Acetonitrile-D 3 ): 6, ppm = 1.77 s (BH, 1H). Raman-spectrum, v, cm- 1 , K[HB(CN) 3 ]: 2462 s, 2430 m, 2235 s, 2222 vs, 1058 w, 728 w, 522 w, 498 vw, 348 s, 180 s, 171 s. 30 Example 3: Potassium hydrido-tricyano-borate - K[BH(CN) 3 1
K[B(CN)
4 ] + KOH - 0.55 H 2 0 -+ K[BH(CN) 3 ] + KCN WO 2012/163489 PCT/EP2012/002179 - 54 A mixture of 10 g (65 mmol) K[B(CN) 4 ] and 22 g (334 mmol) KOH 0.55H 2 0 in 20 cm 3 of diglyme is stirred and heated for 80 min at 160-165 *C. After cooling to room temperature the reaction mixture is dissolved in 40 5 cm 3 of water and product is extracted with tetrahydrofuran (3 x 100 cm 3 ). The THF-extract is dried with K 2 C0 3 , filtered and all volatile components of the mixture are removed in vacuum. The residue is treated with 100 cm 3 of 36%-ige HCl and the solution is evaporated in vacuum at 50-60 *C. The residue is dissolved in 50 cm 3 of acetonitrile and 50 cm 3
CH
2
CI
2 are added 10 to this solution. The mixture is filtered and diluted with 450 cm 3 of CH 2
CI
2 . The precipitant (K[BH(CN) 3 1 - xCH 3 CN) is filtered off and washed with
CH
2
CI
2 . The product, K[BH(CN) 3 ] - xCH 3 CN, is dried in vacuum at 50*C for 15 hours. Yield of solid K[BH(CN) 3 1 is 6.0 g (72%). The product is characterized by means of NMR spectroscopy. The 11
B
15 NMR and 'H{"B}-NMR spectra are identical to in Example 2 described spectra Example 4: Synthesis of M 2
[B(CN)
3 ], (M = Li, Na, K) M[B(CN)4] + 2 M - M 2
[B(CN)
3 ] + MCN 20 M = Li, Na, K 30 mmol of M[B(CN) 4 ] (Merck KGaA, Darmstadt) und 60 mmol M (M = Li, Na or K) are placed into 100 cm 3 glass flask under inert atmosphere (glove box). Ca. 30 cm 3 of liquid ammonia are condensed to this mixture by cooling of reaction vessel with dry ice (-78 *C). The temperature of the 25 reaction mixture is slowly increased to -40 *C (temperature in the cooling bath) until an exothermal reaction was started. During the reaction the blue colour of alkali-metal solution in ammonia disappeared and yellow precipitant was formed from orange solution. The reaction time for K is of about 30 min; for Na is ca. 1 hour and for Li - 2 hours. The side product, 30 MCN, can be washed out with liquid ammonia (in the case of M = K or Na) at -78 *C or with tetrahydrofuran in the case of LiCN. The residue, practically pure M 2
[B(CN)
3 1, is dried in the vacuum at room temperature.
WO 2012/163489 PCT/EP2012/002179 - 55 Raman-spectrum, v, cm-1: Na 2
[B(CN)
3 ]: 2105 vs, 2040 s, 2013 vs, 1993 vs, 1154 w, 1113 w, 577/552 m, 506 w, 174 vs 5 K2[B(CN) 3 1: 2098 vs, 2040 s, 2022 vs, 1997 vs, 1137 w, 1115 w, 561/551 m, 502 w, 194 vs NMR-spectra of [B(CN) 3
]
2 dianion (Solvent: ND 3 , at -40'C; Reference substance K[B(CN)4: 8(11B) = -38.6 ppm and 8( 13 C) = 122.3 ppm): 10 NMR 11 B, 6, ppm: -45.3, 1
J("
1
B,
13 C) = 92 Hz NMR 13 C, 6, ppm: 157.7, 'J("B, 13 C) = 93 Hz K2[B(CN) 3 ] is decomposed above 230 *C (DSC onset) exothermally with colouring (brown). 15 The yellow salts M 2
[B(CN)
3 ] hydrolyze quantitatively with water to the corresponding hydrido-tricyano borates, M[BH(CN) 3 ] which can be isolated from aqueous solution as pure salts in quantitative yield.
M
2
[B(CN)
3 ] + H 2 0 -- M[HB(CN) 3 ] + MOH (M = Li, Na, K) 20 Example 5: 1-ethyl-3-methylimidazolium hydrido-tricyano-borate - [EMIM]
[BH(CN)
3 1 5 C 2 H-N N-CH 3 + K[BH(CN) 3 ] H C 2 H5N N-CH 3 + KCI Cr-
[BH(CN)
3 ] 10.0 g (79 mmol) K[BH(CN) 3 ] dissolved in 50 cm 3 water and 11.6 g (79 mmol) 1-ethyl-3-methylimidazolium chloride, [EMIM]CI in 50 cm 3 water are mixed together at room temperature. The product, 1-ethyl-3 30 methylimidazolium tricyanohydridoborate is extracted with dichloromethane (100 + 50 + 50 cm 3 of CH 2
CI
2 ). The organic phase is washed two times with water (50 + 50 cm 3 ) and dried with Na 2
SO
4 . The solvent is distilled off and WO 2012/163489 PCT/EP2012/002179 - 56 the residue is dried in vacuum at ca. 40 *C for 15 hours. The yield of liquid at room temperature 1-ethyl-3-methylimidazolium tricya nohydridoborate, [EMIM] [BH(CN) 3 1, is 12.2 g (77%). Residual water: 15 ppm. 5 Chloride impurities: 9 ppm (ion-chromatography) Viscosity: 12.2 mPa-s (20 *C). Decomposition temperature: above 277 *C (DSC/TGA; onset). 'H{"B}-NMR (Solvent: Acetonitrile-D 3 ): 6, ppm = 1.49 t (CH 3 , 3H), 3 JH,H 10 7.3 Hz; 1.77 s (BH, 1H); 3.86 s (CH 3 , 3H); 4.20 q (CH 2 , 2H), 3 JH,H = 7.3 Hz; 7.36 d,d (CH, H); 7.42 d,d (CH, H), JH,H = 1.7 Hz; 8.46 br.s (CH, 1H). 1 'B-NMR (Solvent: Acetonitrile-D 3 ): 6, ppm = -40.2 s, 1 JB,H = 97 Hz. 15 Example 6: 1 -butyl-1 -methylpyrrolidinium hydrido-tricyano-borate - [BMPL]
[BH(CN)
3 ] + K[BH(CN) 3 ] + KCI + H 2 0 + N C- N [BH(CN) 3 ]~ 20 C 4
H
9
CH
3
C
4
H
9
CH
3 7.3 g (57 mmol) K[BH(CN) 3 ] dissolved in 20 cm 3 water and 10.1 g (57 mmol) 1-butyl-1-methylpyrrolidinium chloride, [BMPL]CI in 20 cm 3 water 25 are mixed together at room temperature. The product, 1-butyl-1 methylpyrrolidinium tricyanohydridoborate, is extracted with dichloromethane (100 + 50 + 50 cm 3 of CH 2
CI
2 ). The organic phase is washed two times with water (50 + 50 cm 3 ) and dried with Na 2
SO
4 . The solvent is distilled off and the residue is dried in vacuum at ca. 45 0C for 16 30 hours. The yield of liquid at room temperature 1-butyl-1-methylpyrrolidinium tricyanohydridoborate, [BMPL] [BH(CN) 3 ], is 12.6 g (96%).
WO 2012/163489 PCT/EP2012/002179 - 57 'H{"B}-NMR (Solvent: Acetonitrile-D 3 ): 6, ppm = 0.98 t (CH 3 , 3H), JH,H 7.3 Hz; 1.40 t.q (CH 2 , 2H), 3 JH.H = 7.4 Hz, 1.70-1.80 m (CH 2 , 2H); 1.79 s (BH, 1H), 2.18 m (2CH 2 , 4H); 2.98 s (CH 3 , 3H); 3.26 m, (CH 2 , 2H); 3.44 m (2CH 2 , 4H). 5
'
1 B-NMR (Solvent: Acetonitrile-D 3 ): 6, ppm = -40.1 S, 1JB,H = 98 Hz. Viscosity: 26.6 mPa-s (20 *C). Decomposition temperature: above 280 *C (DSC/TGA; onset). 10 Example 7: N,N,N-tri-n-butyl-N-methylammonium hydrido-tricyano-borate [n-Bu 3
NCH
3 ] [BH(CN) 3 ]
K[BH(CN)
3 ] + [(n-C 4
H
9
)
3
NCH
3 ]CI - [(n-C 4
H
9
)
3
NCH
3
][BH(CN)
3 ] + KCI 15 8.84 g (68.5 mmol) K[BH(CN) 3 ] dissolved in 50 cm 3 water and 16.2 g (68.7 mmol) N,N,N-tri-n-butyl-N-methylammonium chloride, [n-Bu 3
NCH
3 ]CI in 50 cm 3 water are mixed together at room temperature. The product, N,N,N-tri n-butyl-N-methylammonium tricyanohydridoborate is extracted with dichloromethane (100 + 50 + 50 cm 3 of CH 2
CI
2 ). The organic phase is 20 washed two times with water (50 + 50 cm 3 ) and dried with Na 2
SO
4 . The solvent is distilled off and the residue is dried in vacuum at ca. 45 0C for 1 day. The yield of liquid at room temperature N,N,N-tri-n-butyl-N methylammonium tricyanohydridoborate, [n-Bu 3
NCH
3 ] [BH(CN) 3 ], is 16.4 g (82%). 25 Content of chloride impurities: 24 ppm (ion-chromatography). Viscosity: 149 mPa-s (20 0C). 'H{"B)-NMR (Solvent: Aceton-D 6 ): 5, ppm = 1.00 t (3CH 3 , 9H), 3JH,H = 7.4 Hz; 1.43 m (3CH 2 , 6H); 1.80 s (BH, 1H), 1.75-1.86 m (3CH 2 , 6H); 3.15 s
(CH
3 , 3H), 3.40 m, (3CH 2 , 6H). 30
'
1 B-NMR (Solvent: Aceton-D 6 ): 6, ppm = -40.0 d, 1 JBH = 97 Hz.
WO 2012/163489 PCT/EP2012/002179 - 58 Example 8: tetra-n-butylphosphonium hydrido-tricyanoborate - [n-Bu 4 P]
[BH(CN)
3 ]
K[BH(CN)
3 ] + [(n-C 4
H
9
)
4 P]OH H~g [(n-C 4
H
9
)
4
P][BH(CN)
3 ] + KOH 5 1.93 g (15.0 mmol) K[BH(CN) 3 ] dissolved in 10 cm 3 of water are mixed at room temperature with 10.4 g (10.5 cm 3 , 15.0 mmol) 40% aqueous solution tera-n-butylphosphonium hydroxyde, [n-Bu 4 P]OH. The product, tera-n butylphosphonium tricyanohydrido-borate is extracted with dichloromethane (100 + 50 + 50 cm 3 of CH 2
CI
2 ). The organic phase is washed two times with 10 water (50 + 50 cm 3 ) and dried with Na 2
SO
4 . The solvent is distilled off and the residue is dried in vacuum at ca. 45 *C for 2 day. The yield of liquid at room temperature tera-n-butylphosphonium tricyanohyd ridoborate, [n-Bu 4 P]
[BH(CN)
3 ], is 4.86 g (89%). 1 H{'B}-NMR (Solvent: Aceton-D 6 ): 6, ppm = 0.98 t (4CH 3 , 12H), 3 JH,H = 7.3 15 Hz; 1.53 m (4CH 2 , 8H); 1.62-1.74 m (4CH 2 , 8H); 1.80 s (BH, 1H), 2.36 m, (4CH 2 , 8H). "B-NMR (Solvent: Aceton-D 6 ): 6, ppm = -40.0 d, IJBH = 97 Hz. 20 Example 9: 1-butyl-3-methylpyridinium hydrido-tricyano-borate - [BMPy]
[BH(CN)
3 ] O CH 3 CH 3 + K[BH(CN) 3 1 H20 + KCl N Cl- N 25 N [BH(CN) 3 ]~ I
C
4
H
9
C
4
H
9 8.08 g (62.7 mmol) K[BH(CN) 3 ] dissolved in 35 cm 3 of water and 11.63 g (62.6 mmol) of 1-butyl-3-methylpyridinium chloride, [BMPy]Cl, dissolved in 30 18 cm 3 of water are mixed together at room temperature. The product, 1 butyl-3-methylpyridinium tricyanohyd ridoborate is extracted with dichloromethane (100 + 50 + 50 cm 3 of CH 2
CI
2 ). The organic phase is WO 2012/163489 PCT/EP2012/002179 - 59 washed two times with water (50 + 50 cm 3 ) and dried with Na 2
SO
4 . The solvent is distilled off and the residue is dried in vacuum at ca. 40 "C for one day. The yield of liquid at room temperaturel-butyl-3-methylpyridinium tricyanohydridoborate, [BMPy] [BH(CN) 3 ], is 13.64 g (91%). 5 1 H-NMR (Solvent: Aceton-D 6 ): 6, ppm = 0.99 t (CH 3 , 3H), 3JH,H = 7.5 Hz; 1.45 m (CH 2 , 2H); 1.74 d (1H, BH), 'JH,B = 97 Hz; 2.09 m (CH 2 , 2H); 2.63 s
(CH
3 , 3H), 4.72 t (CH 2 , 2H), 3 JH,H = 7.6 Hz; 8.10 d,d (CH, 1H), JH,H = 7.0 Hz; 8.50 d (CH, 1H), 3H,H = 8.0 Hz; 8.88 d (CH, 1H), 3 JH,H = 6.1 Hz; 8.94 s 10 (CH, 1H). 1 1 B-NMR (Solvent: Aceton-Ds): 6, ppm = -40.1 d, 1 JB,H = 97 Hz. Example 10: triethyl-sulfonium hyd rido-tricyano-borate, [(C 2
H
5
)
3 S]' 15 [BH(CN) 3 1
K[BH(CN)
3 ] + [(C 2
H
5
)
3 S]l + AgCl -+ [(C 2
H
5
)
3
S][BH(CN)
3 1 + KC + Agl The solution of 52.34 g (308 mmol) AgNO 3 in 200 mL of water is treated with 27 mL 37% HC. Precipitant (AgCI) is filtered off and washed 5 time 20 with 200 mL of water. AgCl obtained in this way is vigorously stirred for 24 hours with 14.45 g (58.7 mmol) of triethyl sulfonium iodide, [Et 3 S]I, in 50 mL of water. The yellow precipitant is filtered off and the aqueous solution of triethyl sulfonium chloride, [Et 3 S]Cl, is reacted with 7.61 g (59.0 mmol) of potassium hydrido-tricyano-borate, K[BH(CN) 3 ]. The reaction mixture is 25 extracted with 100+50+50 mL CH 2
CI
2 . The organic phase is washed with 10+10+10 mL of water and dried with Na 2
SO
4 . The solution is filtered and the solvent is distilled off. The residue is dried in vacuum at 40-50 *C over night. 10.50 g (50.2 mmol) of liquid triethylsulfonium hydrido-tricyano borate, [Et 3
S][BH(CN)
3 ], is obtained Yield is 86% calculating on the triethyl 30 sulfonium iodide used. The product is characterised with the NMR spectra.
WO 2012/163489 PCT/EP2012/002179 - 60 [BH(CN) 3 ]~ 1 H-NMR (Solvent: CD 3 CN), 6, ppm: 1.79 q, 'J('H,"B) = 98 Hz. 11 B-NMR (Solvent: CD 3 CN), 6, ppm: -40.1d, 'J('H,"B) = 98 Hz, 'J( 3
C,
1 1 B) -66 Hz. 5 1 3 C-NMR (Solvent: CD 3 CN), 6, ppm: 128.2 q,d, 'J( 13
C,
11 B) = 66 Hz, 1
J('H,
13 C) = 13 Hz,
[(C
2
H
5
)
3 S]* 1 H-NMR (Solvent: CD 3 CN), 6, ppm: 1.43 t (CH 3 ), JH,H = 7.45 Hz, 'JH,c 10 131 Hz; 3.23 q (CH 2 ), 3JH,H = 7.41 Hz, 'JH,c = 146 Hz. 13 C-NMR (Solvent: CD 3 CN), 6, ppm: 9.0 q,m (CH 3 ), IJCH = 131 Hz, 2JC,H 4 Hz; 33.3 t,m (CH 2 ), 1 JCH = 146 Hz, 2
,
3 JCH = 2-4 Hz, 'Jc,c = 34 Hz. Viscosity and density of triethyl-sulfonium hydrido-tricyano-borate, 15 [Et 3
S][BH(CN)
3 ]: Temperature, *C Viscosity, mPa-s Density, g/cm 3 20 14,65 0,981 40 8,45 0,967 20 60 5,50 0,954 80 3,87 0,941 Example 11: diphenyl-iodonium hydrido-tricyano-borate, [(C 6
H
5
)
2 l]'
[BH(CN)
3 1 25
K[BH(CN)
3 ] + [(C 6
H
5
)
2 1]Cl -H 2 0 [(C 6
H
5
)
2 1][BH(CN) 3 ] + KCI + H 2 0 The solution 0.90 g (6.98 mmol) of K[BH(CN) 3 ] in 10 mL H 2 0 and the solution of 2.27 g (6.80 mmol) of diphenyl iodonium chloride monohydrate, [Ph 2 l]C-H 2 0 in 150 mL CH 2
CI
2 are mixed together. The reaction mixture is 30 diluted with 100 mL of water and two phase system is separated in the funnel. The aqueous phase is additionally extracted two times with 20 mL
CH
2
CI
2 . The combined organic phase is washed with 50 mL of water and WO 2012/163489 PCT/EP2012/002179 - 61 dried with Na 2
SO
4 . The solution is filtered and the solvent is distilled off. The residue is dried in vacuum at 40-50 *C over night. 2.35 g (6.34 mmol) of diphenyl-iodonium hydrido-tricyano-borate, [(C 6
H
5
)
2 1][BH(CN) 3 ], is obtained. Yield is 93% calculating on the diphenyl iodonium chloride 5 monohydrate used. The product is characterised with the NMR spectra.
[BH(CN)
3 ]~ 1 H-NMR (Solvent: CD 3 CN), 6, ppm: 1.90 q, 'J('H,"B) = 98 Hz. 1 B-NMR (Solvent: CD 3 CN), 6, ppm: -39.9 d, 'J('H,"B) = 98 Hz. 10 13 C-NMR (Solvent: CD 3 CN), 6, ppm: 128.2 q,d, 'J( 13
C,B
11 ) = 66 Hz, 1
J('H,
13 C) = 13 Hz, [(CsHs5)21]* 1 H-NMR (Solvent: CD 3 CN), 6, ppm: 7.55 t (CH, 4H), 3JH,H = 7.5 Hz, 7.69 t 15 (CH, 2H), 3 jH H = 7.5 Hz, 8.14 d,d (CH, 4H), 3JHH = 8.5 Hz, 4 JHH = 0.8 Hz. 13 C-NMR (Solvent: CD 3 CN), 6, ppm: 114.3 t,q (2C), JC,H = 11.9 Hz, Jc,H = 2.1 Hz; 133.2 d,d (4C), 'JC,H = 167 Hz, JC,H = 8.1 Hz; 133.7 d,t (2C), 1 JC,H 165 Hz, JCH = 7.4 Hz; 136.0 d,m (4C), 1 JCH = 169 Hz, JCH = 7-8 Hz. 20 Example 12: ditolyl-iodonium hydrido-tricyano-borate, [(4-CH 3
C
6
H
4
)
2 1]J
[BH(CN)
3
]
K[BH(CN)
3 ] + [(4-CH 3
C
6 H4) 2 1][PF 6 ] - [(C 6
H
5
)
2 1][BH(CN) 3 ] + K[PFe] 25. The solution 0.832 g (6.45 mmol) of K[BH(CN) 3 1 in 10 mL CH 3 CN and the solution of 2.680 g (5.90 mmol) of ditolyl-iodonium hexafluorophosphate, [(4-CH 3
C
6 H4) 2 1][PF 6 ], in 5 mL CH 3 CN are mixed together. The precipitate is filtered off and the solution is evaporated on rotary evaporator. The residue is dissolved in 20 mL CH 2
CI
2 , the precipitant is filtered off and washed with 30 10 mL CH 2
CI
2 . The solvent is evaporated on rotary evaporator and the residue is dried in vacuum at 40-50 *C over night. 2.226 g (5.58 mmol) of ditolyl-iodonium hydrido-tricyano-borate, [(4-CH 3
CH
4
)
2 11 [BH(CN) 3 ], is WO 2012/163489 PCT/EP2012/002179 -62 obtained Yield is 95% calculating on the ditolyl iodonium hexafluorophosphate used. The product is characterised with the NMR spectra. 5 [BH(CN) 3 ]~ 1 H-NMR (Solvent: CD 3 CN), 6, ppm: 1.85 q, 'J('H,"B) = 99 Hz. 11 B-NMR (Solvent: CD 3 CN), 6, ppm: -40.0 d, 'J('H,"B) = 99 Hz. 1 3 C-NMR (Solvent: CD 3 CN), 6, ppm: 128.3 q,d, 1 J(1 3
C,B
11 ) = 66 Hz, 1
J('H,
13 C) = 13 Hz. 10 [(4-CH 3
C
6
H
4
)
2 1]* H-NMR (Solvent: CD 3 CN), 6, ppm: 2.38 s (CH 3 , 3H); 7.36 d (CH, 4H), 3 JHH = 8.3 Hz; 7.99 d (CH, 4H), 3JH,H = 8.4 Hz. 13 C-NMR (Solvent: CD 3 CN), 6, ppm: 21.4 q,t (2C, 2CH 3 ), JCH = 128 Hz, 15 3 JC,H = 4.2 Hz; 110.7 t (2C), Jc,H = 12.0 Hz; 134.0 d,d,q (4C), 1 JcH = 164 Hz, Jc,H = 5.8 Hz; 136.0 d,d (4C), 1 JC,H = 170 Hz, Jc,H = 5.7 Hz; 145.2 t,q (2C), JC,H = 6.5 Hz. Example A: Formulations and device 20 The following electrolyte formulations are synthesized to demonstrate the application of electrolyte formulations according to the invention relative to electrolyte formulations of the prior art containing emim TCB in dye sensitized solar cells. 25 The electrolyte formulations are prepared through mixing of one or more of 1,3-dimethylimidazolium iodide (mmiml), 1-propyl-3-methylimidazolium iodide (pmiml), iodine, N-butylbenzimidazole (NBB) and guanidinium thiocyanate (guaSCN) and the corresponding ionic liquid as indicated such 30 as emim TCB and emim [BH(CN) 3 ] (emim MHB) or bmpl TCB and bmpl
[BH(CN)
3 ] (N-butyl-N-methylpyrrolidinium monohydridotricyanoborate = bmpl MHB) in weight% as listed below.
WO 2012/163489 PCT/EP2012/002179 - 63 Electrolyte 1 molar ratio[%] theoretical value in weight % 12 3.1 3.5 mmim 1 22.4 22.0 5 pmim I 22.4 24.8 guaSCN 1.2 0.6 NBB 6.2 4.8 emim TCB 44.7 44.3 total 100 100 10 Electrolye 1 is measured three times. Electrolyte 2 molar ratio[%] theoretical value in weight % 12 3.1 3.6 15 mmim 1 22.4 22.8 pmim I 22.4 25.7 guaSCN 1.2 0.7 NBB 6.2 4.9 emim [BH(CN) 3 1 44.8 42.3 20 total 100 100 Electrolye 2 is measured three times. Electrolyte 3 weight% 25 12 1,3 mmim 1 35 guaSCN 0,7 NBB 3 emim TCB 60 30 total 100 Electrolye 3 is measured two times.
WO 2012/163489 PCT/EP2012/002179 - 64 Electrolyte 4 weight% 12 1,3 5 mmim 1 35 guaSCN 0,7 NBB 3 emim [BH(CN) 3 ] 60 total 100 10 Electrolye 4 is measured two times. Electrolyte 5 weight% 15 12 1,3 mmim 1 35 guaSCN 0,7 NBB 3 bmpl TCB 60 20 total 100 Electrolye 5 is measured two times. Electrolyte 6 weight% 25 12 1,3 mmim l 35 guaSCN 0,7 NBB 3 bmpI [BH(CN) 3 ] 60 30 total 100 Electrolye 6 is measured two times.
WO 2012/163489 PCT/EP2012/002179 - 65 The above cited compounds are commercially available or are synthesized according to known literature methods. 5 The dye sensitized solar cells for the following measurements (masterplates) are commercially available from ISE (Institut for solare Energiesysteme, Freiburg), serial no. 010311 which are fabricated based on the disclosure of US 5,728,487 or WO 2007/093961: 10 The used titaniumdioxide paste is commercially available from Dyesol, Australia, serial no. DSL 18 NRT and DSL 18NRTAO. The titanium dioxide is screen printed three times: two times with the titaniumdioxide paste DSL 18 NRT (each layer thickness = 2 im) and one 15 time with the titaniumdioxide paste DSL 18NRT AO (layer thickness 5 to 6 pjm). The masterplate is irrigated with a solution of 30 mg Z907 dye in 62.5 ml ethanol for 6 hours. The electrolyte formulations as described above are filled into the internal 20 space of the prepared masterplate to produce the corresponding devices. The dye Z907 is an amphiphilic ruthenium sensitizer Ru(2,2'-bipyridine 4,4' dicarboxylic acid) (4,4'-dinonyl-2,2'-bipyridine)(NCS) 2 or synonymously [Ru(H2dcbpy)(dnbpy)(NCS) 2 . 25 The measurements of photocurrent-voltage curves are carried out under Solarsimulator Sun 2000 from Abet Technologies, Model 11018, with temperature control for devices fabricated as described above containing electrolytes 1 to 6 placed on a black plate chilled down to 25 0 C under 1 Sun 30 illumination. The measured area of the solar cell is 5mm to 25 mm.
WO 2012/163489 PCT/EP2012/002179 - 66 Energy conversion efficiency is generally the ratio between the useful output of an energy conversion machine and the input of light radiation, in energy terms, determined by using adjustable resistant load to optimize the electric power output. 5 Table 1 summarizes the results of the measurements of the above cited electrolyte formulations as average values: Electrolyte Jsc [mAcm- 2 ] Voc [V] FF [ q%] [%] 1* 9.0 0.65 66.8 3.9 2 8.9 0.67 67.8 4.1 10 3* 7.2 0.62 57.5 2.6 4 7.85 0.62 60.8 3.0 5* 4.65 0.62 54.5 1.6 6 5.1 0.62 53.5 1.7 15 * not according to the invention Jsc = short circuit current Voc = open circuit voltage FF = fill factor 20 T = power conversion efficiency Table 1 documents that electrolytes comprising hydridotricyanoborate as anion perform better or equal than electrolytes comprising TCB as anion if the same cation is used. 25 Example B: Formulations and device The following electrolyte formulations are synthesized to demonstrate the unexpected advantage of electrolyte formulations according to the invention relative to electrolyte formulations of the prior art containing emim TCB. 30 The electrolyte formulations are prepared through mixing of one or more of 1,3-dimethylimidazolium iodide (mmiml), 1-ethyl-3-methylimidazolium WO 2012/163489 PCT/EP2012/002179 - 67 iodide (emiml), 1-propyl-3-methylimidazolium iodide (pmiml), 1-allyl-3 methylimidazolium iodide (allylMIMI), iodine, N-butylbenzimidazole (NBB), guanidinium thiocyanate (guaSCN), y-butyrolacton (GBL) and tetraethylenglycoldimethylether (TG) and the corresponding ionic liquid as 5 indicated such as emim TCB, B3MPYR TCB (1-Butyl-3-methyl-pyridinium tetracyanoborate), emim [BH(CN) 3 1, bmpl [BH(CN) 3 1 (N-butyl-N methylpyrrolidinium hydridotricyanoborate) or B3MPYR [BH(CN) 3 ] (1-Butyl 3-methyl-pyridinium hydridotricyanoborate) in weight% as listed below. 10 Electrolyte 7 weight % 12 3.5 pmim 1 21 mmim 1 20 guaSCN 0.5 15 NBB 5 emim TCB 25 GBL 25 total 100 20 Electrolyte 8 weight % 12 3.5 pmim 1 21 mmim 1 20 guaSCN 0.5 25 NBB 5 emim MHB 25 GBL 25 total 100 30 Electrolyte 9 weight % 12 3.5 pmim l 21 WO 2012/163489 PCT/EP2012/002179 - 68 mmim 1 20 guaSCN 0.5 NBB 5 emim TCB 25 5 TG 25 total 100 Electrolyte 10 weight % 12 3.5 10 pmim 1 21 mmim 1 20 guaSCN 0.5 NBB 5 emim MHB 25 15 TG 25 total 100 Electrolyte 11 weight % 12 4.1 20 emim I 27.9 mmim 1 26.2 guaSCN 0.8 NBB 5.7 emim TCB 35.3 25 total 100 Electrolyte 12 weight % 12 4.3 emim I 29.0 30 mmim 1 27.2 guaSCN 0.8 NBB 5.9 WO 2012/163489 PCT/EP2012/002179 - 69 emim MHB 32.8 total 100 Electrolyte 13 weight % 5 12 4.3 emim 1 15 mmim I 14.2 allylMIMI 15.1 guaSCN 0.8 10 NBB 5.9 emim TCB 44.7 total 100 Electrolyte 14 weight % 15 12 4.3 emim 1 15 mmim I 14.2 allylMIMI 15.1 guaSCN 0.8 20 NBB 5.9 emim MHB 44.7 total 100 Electrolyte 15 weight % 25 12 3.5 pmim 1 24.8 mmim 1 22 guaSCN 0.6 NBB 4.8 30 b3mpyr TCB 44.6 total 100 WO 2012/163489 PCT/EP2012/002179 - 70 Electrolyte 16 weight % 12 3.5 pmim I 24.8 mmiml 22 5 guaSCN 0.6 NBB 4.8 b3mpyr MHB 44.6 total 100 10 The above cited compounds are commercially available or are synthesized according to known literature methods. The dye sensitized solar cells for the following measurements (masterplates) are commercially available from ISE (Institut fur solare 15 Energiesysteme, Freiburg), serial no. 010311 which are fabricated based on the disclosure of US 5,728,487 or WO 2007/093961: The used titaniumdioxide paste is commercially available from Dyesol, Australia, serial no. DSL 18 NRT and DSL 18NRT AO. 20 The titanium dioxide is screen printed three times: two times with the titaniumdioxide paste DSL 18 NRT (each layer thickness = 2 pm) and one time with the titaniumdioxide paste DSL 18NRT AO (layer thickness 5 to 6 ptm). 25 The masterplate is irrigated with a solution of 30 mg Z907 dye in 62.5 ml ethanol for 4 hours. The electrolyte formulations as described above are filled into the internal space of the prepared masterplate to produce the corresponding devices. 30 WO 2012/163489 PCT/EP2012/002179 - 71 The dye Z907 is an amphiphilic ruthenium sensitizer Ru(2,2'-bipyridine 4,4' dicarboxylic acid) (4,4'-dinonyl-2,2'-bipyridine)(NCS) 2 or synonymously [Ru(H2dcbpy)(dnbpy)(NCS) 2 ]. 5 The measurements of photocurrent-voltage curves are carried out under Solarsimulator Sun 2000 from Abet Technologies, Model 11018, with temperature control for devices fabricated as described above containing electrolytes 7 to 14 placed on a black plate chilled down to 25*C under 1 Sun illumination. The measured area of the solar cell is 5mm to 25 mm. 10 Energy conversion efficiency is generally the ratio between the useful output of an energy conversion machine and the input of light radiation, in energy terms, determined by using adjustable resistant load to optimize the electric power output. 15 Table 2 summarizes the results of the measurements of the above cited electrolyte formulations as average values: Electrolyte Jsc [mAcm- 2 ] Voc [V] FF [%] T [%] 20 7* 9.9 0.62 67.3 4.2 8 9.8 0.63 0.68 4.2 9* 8.3 0.62 0.61 3.1 10 8.5 0.63 0.59 3.2 11* 8.3 0.62 0.67 3.5 25 12 8.7 0.62 0.66 3.6 13* 7.5 0.61 0.66 3.0 14 7.3 0.61 0.67 3.0 15* 7.8 0.58 0.45 2.0 16 8.1 0.58 0.44 2.1 30 * not according to the invention Jsc = short circuit current WO 2012/163489 PCT/EP2012/002179 - 72 Voc = open circuit voltage FF = fill factor 1 = power conversion efficiency 5 Table 2 documents that electrolytes comprising hydridotricyanoborate as anion perform better or comparable to electrolytes comprising TCB as anion if the same cation is used. Example C: formulation and device 10 The following electrolyte formulations are synthesized to demonstrate the unexpected advantage of electrolyte formulations according to the invention (emim MHB) relative to corresponding electrolyte formulations containing emim TCB. 15 The electrolyte formulations are prepared through mixing of 1,3 dimethylimidazolium iodide (mmiml), iodine, N-butylbenzimidazole (NBB), guanidinium thiocyanate (guaSCN) and the corresponding ionic liquid as indicated such as emim TCB, emim [BH(CN) 3 ] (emim MHB) or mixtures of emim TCB and emim MHB in weight% as listed below. 20 Table 3: electrolytes 11 to 15 Electrolyte 17* 18 19 20 21 Ingredients in weight% 25 12 1.3 1.3 1.3 1.3 1.3 mmiml 35,0 35,0 35,0 35,0 35,0 guaSCN 0.7 0.7 0.7 0.7 0.7 emim TCB 60.0 45.0 30.0 15.0 0.0 emim MHB 0.0 15.0 30.0 45.0 60.0 30 NBB 3.0 3.0 3.0 3.0 3.0 * not according to the invention WO 2012/163489 PCT/EP2012/002179 -73 The dye sensitized solar cells are fabricated as disclosed in US 5,728,487 or WO 2007/093961: 5 A double-layer, mesoporous TiO 2 electrode was prepared as disclosed in Wang P et al., J. Phys. Chem. B 2003, 107, 14336, in particular page 14337, in order to obtain a photoanode consisting of a double layer structure. To prepare a transparent nanoporous TiO 2 electrode, a screen printing paste containing terpineol solvent and nanoparticulate TiO 2 of 10 anatase phase with 20 nm diameter was deposited on a transparent conductive substrate to 5 mm x 5 mm squared shape by using a hand printer. The paste was dried for 10 minutes at 120 degrees Celsius. Another screen printing paste containing TiO 2 with 400 nm diameter was then deposited on top of the nanoporous layer to prepare an opaque layer. 15 The double layer film was then sintered at 500 degrees Celsius for an hour with the result of an underlying transparent layer (7 microns thick) and a top opaque layer (4 microns thick). After sintering, the electrode was immersed in 40 mM aqueous solution of TiCl 4 (Merck) for 30 minutes at 70 degrees Celsius and then rinsed with pure water sufficiently. Thus TiCl 4 -treated 20 electrode was dried at 500 degrees Celsius for 30 minutes just before dye sensitization. The electrode was dipped into a dye solution being 0.3mM for the dye C106 and 0.075 mM for DINHOP (solvent mixture acetonitrile (Merck HPLC grade) and tert-butyl alcohol (Merck), v:v = 1:1) for 64 hours at 6 degrees Celsius. The counter electrode was prepared with thermal 25 pyrolysis method as disclosed in the reference above. A droplet of 5 mM solution of platinic acid (Merck) was casted at 8 pl/cm2 and dried on a conductive substrate. The dye sensitized solar cell was assembled by using 30 micron thick Bynel (DuPont, USA) hot-melt film to seal up by heating. The internal space was filled with each of the electrolyte formulations as 30 described above to produce the corresponding devices.
WO 2012/163489 PCT/EP2012/002179 - 74 In order to obtain accurate light intensity level, Air Mass 1.5 Global (AM 1.5G) simulated sunlight is calibrated spectrally according to Seigo Ito et al, "Calibration of solar simulator for evaluation of dye-sensitized solar cells", Solar Energy Materials & Solar Cells, 82, 2004, 421. 5 The measurements of photocurrent-voltage curves are carried out under Air Mass 1.5 simulated sunlight (AM 1.5) with temperature control for devices fabricated as described above containing electrolytes 1 to 4 placed on a black plate chilled down to 25 0 C under 1 Sun illumination. A photomask of 4 10 mm x 4 mm is placed on top of the devices to define the light projection area. The cell gap is around 20 micron. Energy conversion efficiency is generally the ratio between the useful output of an energy conversion machine and the input of light radiation, in 15 energy terms, determined by using adjustable resistant load to optimize the electric power output. Table 4-A summarizes the results of the measurements of the above cited electrolyte formulations: 20 Electrolyte Jsc [mAcm- 2 ] Voc [V] FF r [%] 17* 11.03 0.72 0.73 5.72 18 10.00 0.74 0.68 5.03 19 11.41 0.74 0.73 6.14 25 20 11.35 0.74 0.74 6.25 21 12.14 0.73 0.76 6.82 * not according to the invention Jsc = short circuit current 30 Voc = open circuit voltage FF = fill factor T = power conversion efficiency WO 2012/163489 PCT/EP2012/002179 - 75 Table 4-A documents that electrolytes comprising monohydridotricyanoborate as anion or electrolytes comprising mixtures of monohydridotricyanoborate and tetracyanoborate anions perform better 5 than electrolytes comprising TCB as anion if the same cation is used. The performance of a heat stress test (85 0 C) for electrolytes of table 4 documents that the electrolytes 18, 19 and 20 have the high efficiency of the inventive monohydridotricyanoborate and the high stability of tetracyanoborate. 10 The dye sensitized solar cells are fabricated and measured as disclosed before but with the dye Z907 without the additive DINHOP. Table 4-B summarizes the results of the measurements of the above cited electrolyte formulations: 15 Electrolyte Jsc [mAcm 2 ] Voc [V] FF 1 [%] 17* 10.63 0.71 0.64 4.84 18 11.66 0.72 0.66 5.55 19 11.96 0.71 0.68 5.79 20 12.41 0.71 0.68 6.03 20 21 11.63 0.73 0.70 5.88 * not according to the invention Jsc = short circuit current Voc = open circuit voltage 25 FF = fill factor q = power conversion efficiency Example D: formulation and device The following electrolyte formulations are synthesized to demonstrate the 30 unexpected advantage of electrolyte formulations according to the invention (emim MHB) together with a list of additives.
WO 2012/163489 PCT/EP2012/002179 - 76 The electrolyte formulations are prepared through mixing of 1,3 dimethylimidazolium iodide (mmiml), iodine, guanidinium thiocyanate (guaSCN), emim [BH(CN) 3 ] (emim MHB) with and without additives as 5 listed below. gual means guanidinium iodide. Table 5: electrolytes 22 to 26 Electrolyte 22 23 24 25 26 10 Ingredients in weight% 12 1.5 1.5 1.5 1.4 1.5 mmiml 36.7 35.8 36.0 34.8 35.9 guaSCN 0.7 0.7 0.7 0.7 0.7 15 emim MHB 61.1 59.7 59.9 58.0 59.9 NBB 0.0 0.0 0.0 2.0 0.0 Benzimid- 0.0 2.3 0.0 0.0 0.0 azole gual 0.0 0.0 2.0 3.0 0.0 20 emim SCN 0.0 0.0 0.0 0.0 2.0 The dye sensitized solar cells are fabricated and measured as disclosed in example C with Z907, with the dye C106/DINHOP and with the dye D358. 25 Table 6 summarizes the results of the measurements of the above cited electrolyte formulations: Electrolyte Jsc [mAcm- 2 ] Voc [V] FE 1 [%] Z907 30 22 12.05 0.72 0.72 6.30 23 11.04 0.76 0.72 6.00 WO 2012/163489 PCT/EP2012/002179 -77 24 11.80 0.75 0.70 6.20 25 10.63 0.80 0.74 6.62 26 11.83 0.76 0.73 6.60 C106 5 22 13.75 0.68 0.71 6.57 23 12.50 0.71 0.73 6.53 D358 22 12.18 0.65 0.68 5.36 24 12.75 0.64 0.68 5.62 10 25 10.73 0.72 0.72 5.52 26 11.75 0.67 0.70 5.45 Example E: formulation and device The following electrolyte formulations are synthesized to demonstrate the 15 unexpected advantage of electrolyte formulations according to the invention: The electrolyte formulations are prepared through mixing of 1-ethyl-3 methylimidazolium iodide (emiml) or 1,1-dimethylpyrrolidinium iodide 20 (mmpll), iodine, N-butylbenzimidazole (NBB), guanidinium thiocyanate (guaSCN) and the corresponding ionic liquid as indicated such as bmpI TCB, bmpi MHB (bmpl = 1-butyl-1-methylpyrrolidinium), triethylsulfonium monohydridotricyanoborate (et3S MHB), 3-methylpyridinium monohydridotricyanoborate (B3MPYR MHB) and or. 25 Table 7: electrolytes 27 to 32 Electrolyte 27* 28 29* 30 31 32 Ingredients in weight% 30 12 1.3 1.3 1.3 1.3 1.3 1.3 emiml 35.0 35.0 0.0 0.0 35.0 35.0 WO 2012/163489 PCT/EP2012/002179 -78 mmpll 0.00 0.00 35.00 35.00 0.00 0.00 guaSCN 0.7 0.7 0.7 0.7 0.7 0.7 bmpl TCB 60.0 0.00 60.0 0.00 0.00 0.00 bmpl MHB 0.00 60.0 0.00 60.0 0.00 0.00 5 et3S MHB 0.00 0.00 0.00 0.00 60.0 0.00 B3MPYR 0.00 0.00 0.00 0.00 0.00 60.0 MHB NBB 3.0 3.0 3.0 3.0 3.0 3.0 * not according to the invention 10 The dye sensitized solar cells are fabricated and measured as disclosed in example C but with the dye Z907. Table 8 summarizes the results of the measurements of the above cited 15 electrolyte formulations: Electrolyte Jsc [mAcm 2 ] Voc [V] FF [%] 27* 9.27 0.72 0.60 4.02 28 11.38 0.74 0.64 5.37 20 29* 5.42 0.71 0.62 2.38 30 7.37 0.72 0.58 3.10 31 11.81 0.71 0.71 5.95 32 11.78 0.69 0.61 4.95 not according to the invention 25 30

Claims (15)

1. Compounds of formula I [Kt]z+ z[BH(CN) 3 ]~ I 5 in which [Kt]z+ denotes an inorganic or organic cation and z is 1, 2, 3 or 4,where sodium hydrido-tricyano-borate, potassium hydrido-tricyano borate, silver hydrido-tricyano-borate and [(Phenyl) 3 P-N=N-P(Phenyl) 3 ]hydrido-tricyano-borate are excluded. 10 2. Compounds according to claim 1, characterised in that [Kt]z+ is an organic cation selected from the group comprising iodonium, tritylium, sulfonium, oxonium, ammonium, phosphonium, uronium, thiouronium, guanidinium cations or heterocyclic cations. 15 3. Compounds according to claim 1 or 2, in which Ktz+ denotes an inorganic cation selected from the group of H*, NO*, Li , Mg 2 +, Cu*, Cu 2 +, Zn2+,Ca2+ y.3, Yb+3, La+ 3 , Sc+ 3 , Ce+3, Nd+3, Tb+3, Sm+ 3 or complex (ligands containing) metal cations which include rare earths, transitions or noble metals like rhodium, ruthenium, iridium, 20 palladium, platinum, osmium, cobalt, nickel, iron, chromium, molybdenum, tungsten, vanadium, titanium, zirconium, hafnium, thorium, uranium, gold, or an organic cation selected from the group of 25 tritylium cation, in which the phenyl groups may be substituted by straight-chain or branched alkyl groups having 1 to 20 C atoms, straight-chain or branched alkenyl having 2 to 20 C atoms and one or more double bonds or straight-chain or branched alkynyl having 2 to 20 C atoms and one or more triple bonds, 30 an oxonium cation of formula (1) or a sulfonium cation of formula (2) [(R*) 3 0]* (1) WO 2012/163489 PCT/EP2012/002179 -80 [(R*) 3 S]* (2), where R* each independently of one another denotes a straight-chain or branched alkyl group having 1-8 C atoms, non-substituted phenyl or phenyl which is substituted by R', OR', N(R') 2 , CN or halogen and in 5 case of sulfonium cations of formula (2) additionally denotes each independently (R"') 2 N and R' is independently of each other H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C1- to C1 8 -alkyl, saturated C3- to C 7 -cycloalkyl, non substituted or substituted phenyl, Rl* is independently of each other 10 non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C1- to C18-alkyl, saturated C3- to C 7 -cycloalkyl, non substituted or substituted phenyl and R"' is independently of each other straight-chain or branched C1 to C6 alkyl; 15 an ammonium cation, which conforms to the formula (3) [NR 4 ]* (3), where R in each case, independently of one another, denotes H, OR', N(R') 2 , with the proviso that a maximum of one R in formula (3) 20 is OR' or N(R') 2 , straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or 25 more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two R may be fully substituted by halogens, in particular 30 -F and/or -Cl, and one or more of the substituents R may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -CN, -N(R') 2 , -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , WO 2012/163489 PCT/EP2012/002179 - 81 -SO 2 N(R') 2 , -C(O)X, -SO 2 OH, -SO 2 X, -NO 2 , -SR', -S(O)R', -SO 2 R' and where one or two non-adjacent carbon atoms in R which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -SO 2 -, -S020-, -C(O)-, -C(0)0-, -N*(R') 2 -, 5 -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 1 8 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non substituted or substituted phenyl and X each independently is halogen; 10 a phosphonium cation, which conforms to the formula (4) [P(R2 ) 4 1+ (4), where R 2 in each case, independently of one another, denotes 15 H, OR' or N(R') 2 , straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or 20 more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two R 2 may be fully substituted by halogens, in particular 25 -F and/or -Cl, and one or more of the substituents R 2 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -CN, -N(R') 2 , -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2 N(R') 2 , -C(O)X, -SO 2 OH, -SO 2 X, -NO 2 , -SR', -S(O)R', -SO 2 R' and where one or two non-adjacent carbon atoms in R 2 which are not in the 30 a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -SO 2 -, -S0 2 0-, -C(O)-, -C(O)O-, -N'(R') 2 -, WO 2012/163489 PCT/EP2012/002179 - 82 -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C 1 8 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non 5 substituted or substituted phenyl and X each independently is halogen; a uronium cation, which conforms to the formula (5) [C(NR 3 R 4 )(OR 5 )(NR 6 R 7 )]* (5), where 10 R 3 to R 7 each, independently of one another, denote H, where H is excluded for R 5 , straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 15 straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two of the substituents R 3 to R 7 may 20 be fully substituted by halogens, in particular -F and/or -Cl, and one or more of the substituents R 3 to R 7 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2 N(R') 2 , -C(O)X, SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non 25 adjacent carbon atoms in R 3 to R 7 which are not in the c-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -SO2-, -SO20-, -C(0)-, -C(0)O-, -N*(R')2-, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially 30 fluorinated or perfluorinated straight-chain or branched C- to C 18 -alkyl, saturated C3- to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen; WO 2012/163489 PCT/EP2012/002179 - 83 a thiouronium cation, which conforms to the formula (6) [C(NR 3 R 4 )(SR 5 )(NR 6 R* 7 )] (6), where 5 R 3 to R 7 each, independently of one another, denote H, where H is excluded for R 5 , straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 10 straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, where one or two of the substituents R 3 to R 7 may 15 be fully substituted by halogens, in particular -F and/or -Cl, and one or more of the substituents R 3 to R 7 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, -C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2 N(R') 2 , -C(O)X, SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non 20 adjacent carbon atoms in R 3 to R 7 which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, -SO2-, -SO20-, -C(O)-, -C(O)O-, -N*(R')2-, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'- where R' each independently is H, non-fluorinated, partially 25 fluorinated or perfluorinated straight-chain or branched C 1 - to C 1 8 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen; a guanidinium cation, which conforms to the formula (7) 30 [C(NR 8 R 9 )(NR 1 0 R'l)(NR 12 R 13 )]* (7), where R 8 to R 13 each, independently of one another, denote WO 2012/163489 PCT/EP2012/002179 - 84 H, -CN, N(R') 2 , -OR', straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 5 straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, 10 where one or two of the substituents R 8 to R 13 may be fully substituted by halogens, in particular -F and/or -Cl, and one or more of the substituents R 8 to R1 3 may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', -N(R') 2 , -CN, -C(O)OH, C(O)OR', -C(O)R', -C(O)N(R') 2 , -SO 2 N(R') 2 , -C(O)X, -SO 2 OH, -SO 2 X, 15 SR', -S(O)R', -SO 2 R', -NO 2 and where one or two non-adjacent carbon atoms in Ra to R 13 which are not in the a-position may be replaced by atoms and/or atom groups selected from the group -0-, -S-, -S(O)-, SO2-, -SO20-, -C(O)-, -C(0)O-, -N*(R')2-, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'-, 20 where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C1 8 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen; 25 a heterocyclic cation which conforms to the formula (8) [HetN]z+ (8) where HetNz+ denotes a heterocyclic cation selected from the group 30 WO 2012/163489 PCT/EP2012/002179 - 85 imidazolium 1 H-pyrazoiium 3H-pyrazolium 4H-pyrazoiium 1-pyrazolinium Rz Rz R 2 1 R 2 , R 2 , R 2 , R 2 1 R R 2 ' R 2 1 -RX RY RX R 3 RlrIN ,N .R4. R 2 ' ) N'\- R 4 'R2"N N z N R_ N N T+ I+ N RZ Nx N 5 2 " "R R"
2-pyrazolinium 3-pyrazolinium 2,3-dihydroimidazoinium 4,5-dihydroimidazolinium RT R2' RT R 7 RT R2' R
3 R 3 R 3 -+Rz + RX R 2 N 4 R 7 N'\R 4 ' N N.-.R4 R4'z I + I R" RI' T 10R "RT Rz Rz 2,5-dihydroimidazolinium pyrrolidiflium 1 ,2,4-triazolium 1 ,2,4-triazolium 1,2, 3-triazolium R 3 ' RT RV 2 R 2 - 4 + R7 R 4 ' R R'R 2 - R 3 ' N N N-N /+ N N- . -. I ,N -' R Rz N +R 3 , Rz -N' R 4 1 Rz 7 N Rz Rl \+I +I RY RZ R" R 4 1 R"R"z 1 5 pyridinium pyridazinium pyrimidinium 1,2,3-triazolium piperidinium NR 3 R z N~~N\R / \-+-N R 3 ' 20 RR"R R R4 /\ morpholinium piperazinium piperazinium pyrazinium thiazolium R" Ri R 4 ' RV' RV' I R 3 ' \+/ RTK R R 3 ' R' R3 R3, RZ R Rz RRRz S,, Rz, ' NAW R N RZ N S, R 7 \+ R 3 ' /Z\+ RV' /\+ R3' I~ + +R R'R R4R, R 4 ' R" 2 25 30 WO 2012/163489 PCT/EP2012/002179 -86 indolium quinolinium isoquinolinium oxazolum Rz R2 R 7 Rz R2 R2 Rz Rz Rz Rz R2- RZ RR . .,- "N 0 NR Rz N + RR N + R2 + Rz Rz + R' 5 R7 R R 4 ' Rr RT , RT Rz quinoxalinium indolinium benzimidazolium Rz Rz R2, Pyrylium 0 R4 2 N R' R 3 ' R2 N N R' R 2 R 1 R 4 ' R2 R Chromylium (1-Benzopyrylium) Isochromylium (2-Benzopyrylium) Rz R 2' R 2 RT R 2 ' 'z R 2 > 2 15 R2 R 2 ' R 2 O R or R2' R2' where the substituents R"' to R 4 ' each, independently of one another, denote H, 20 straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, 25 saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by straight-chain or branched alkyl groups having 1-6 C atoms, saturated, partially or fully unsaturated heteroaryl, heteroaryl-C-C 6 alkyl or aryl-C-C 6 -alkyl and 30 R 2 denote additionally F, Cl, Br, I, -CN, -OR', -N(R') 2 , -P(O)(R') 2 , P(O)(OR') 2 , -P(O)(N(R') 2 ) 2 , -C(O)R', -C(O)OR', -C(O)X, -C(O)N(R') 2 , SO 2 N(R') 2 , -SO 2 OH, -SO 2 X, -SR', -S(O)R', -SO 2 R' and/or NO 2 , with the WO 2012/163489 PCT/EP2012/002179 - 87 proviso that R", R 3 ', R 4 ' are in this case independently of each other H and/or a straight-chain or branched alkyl having 1-20 C atoms, straight chain or branched alkenyl having 2-20 C atoms and one or more double bonds, 5 where the substituents R", R 2 , R 3 and/or R4' together may also form a ring system, where one to three substituents R" to R4' may be fully substituted by halogens, in particular -F and/or -Cl, and one or more substituents R 1 10 to R4' may be partially substituted by halogens, in particular -F and/or -Cl, and/or by -OH, -OR', N(R') 2 , -CN, -C(O)OH, -C(O)OR', -C(O)R', C(O)N(R') 2 , -SO 2 N(R') 2 , -C(O)X, -SO 2 OH, -SO 2 X, -SR', -S(O)R', SO 2 R', -NO 2 , but where R" and R4' cannot simultaneously be fully substituted by halogens and where, in the substituents R" to R 4 , one or 15 two non-adjacent carbon atoms which are not bonded to the heteroatom may be replaced by atoms and/or atom groups selected from the -0-, -S-, -S(O)-, -SO 2 -, -S0 2 0-, -C(O)-, -C(O)O-, -N*(R') 2 -, -P(O)R'O-, -C(O)NR'-, -SO 2 NR'-, -OP(O)R'O-, -P(O)(N(R') 2 )NR'-, -P(R') 2 =N- or -P(O)R'-, 20 where R' each independently is H, non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C 1 - to C 18 -alkyl, saturated C 3 - to C 7 -cycloalkyl, non-substituted or substituted phenyl and X each independently is halogen or 25 a iodonium cation which conforms to the formula (9) Ar-I-Ar (9) where the aryl group Ar denotes each independently of each other aryl with 6 30 to 30 C atoms which is non-substituted or substituted with at least a straight-chain or branched alkyl group having 1 to 20 C atoms, a straight-chain or branched alkenyl group having 2 to 20 C atoms and WO 2012/163489 PCT/EP2012/002179 - 88 one or more double bonds, a straight-chain or branched alkynyl group having 2 to 20 C atoms and one or more triple bonds, R 1 , NO 2 , SR', N(R') 2 , CN and/or halogen and where R' each independently is H, non-fluorinated, partially fluorinated 5 or perfluorinated straight-chain or branched Cr- to C 18 -alkyl, saturated C3- to C 7 -cycloalkyl, non-substituted or substituted phenyl and where Rl* each independently is non-fluorinated, partially fluorinated or perfluorinated straight-chain or branched C- to C 1 8 -alkyl, saturated C3 to C 7 -cycloalkyl, non-substituted or substituted phenyl 10 and halogen is F, Cl, Br or I.
4. Process for the preparation of a compound of formula I according to claim 1 in which [Kt]z+ is an alkali metal cation and z denotes 1 which 15 denotes a compound of formula 1-1 including sodium hydrido-tricyano borate and potassium hydrido-tricyano-borate, [Me]* [BH(CN) 3 ]~ I-1 comprising in step 1 the reaction of a compound of formula I [Me']+ [B(CN) 4 ]- I 20 with an alkali metal [Me], where [Me']+ in formula Il denotes an alkali metal cation which is different or equal to the alkali metal [Me] resulting in the formation of a compound of formula Ill {[Me]*} 2 [B(CN) 3 ] 2 - III 25 in which [Me]* denotes the alkali metal cation of the alkali metal and comprising in step 2 the hydrolysis of the compound of formula IlIl resulted from step 1.
5. Process for the preparation of a compound of formula I according to 30 claim 1 in which [Kt]z+ is the cation of potassium and z denotes 1 which denotes a compound of formula 1-2 [K]* [BH(CN) 3 1- 1-2 WO 2012/163489 PCT/EP2012/002179 - 89 comprising the reaction of a compound of formula IV [Me 2 ]+ [BH 4 ]~ IV in which [Me 2 ] + denotes an alkali metal cation with {4 KSCN + K 2 [Zn(SCN)4]} and purification from minor amounts of 5 the optional side product K[BH 2 (CN) 2 ].
6. Process for the preparation of a compound of formula I according to claim 1 in which [Kt]z+ is an alkali metal cation and z denotes 1 comprising the reaction of a compound of formula II 10 [Me']+ [B(CN)4]- II with a strong base, preferably an alkali metal hydroxide, an alkali metal amide, a substituted amide or alkali metal alcoholate, where [Me']* in formula I denotes an alkali metal cation which is different or equal to the alkali metal cation of the alkali metal hydroxide, alkali metal amide 15 or alkali metal alcoholate.
7. Process for the preparation of a compound of formula I according to one or more of claims 1 to 3 in which [Kt]z+ is another cation than the used alkali metal cation in the starting material and z denotes 1, 2, 3 or 20 4 including sodium hydrido-tricyano-borate, potassium hydrido-tricyano borate and silver hydrido-tricyano-borate in a salt-exchange reaction, characterized in that an alkali metal salt of formula 1-1 [Me]* [BH(CN) 3 1 1-1 in which [Me]+ is an alkali metal cation or H[BH(CN) 3 ] is reacted with a 25 compound of formula V KtA V, in which Kt has a meaning of an organic cation or inorganic cation other than the alkali metal cation of the compound of formula 1-1 or H* and 30 A denotes F~, CI-, Br-, I-, OH-, [HF 2 ]~, [CN], [SCN]-, [R 1 COO], [R 1 0C(0)0]~, [R 1 S0 3 ] , [R 2 COO]-, [R 2 SO 3 ]~, [R 1 0S0 3 1 -, [PF 6 ]-, [BF 4 ] , [S04] 2-. [HSO 4 ] ~, [N0 3 ]~, [(R 2 ) 2 P(0)0], [R 2 P(0)0 2 ] 2 -, [(R 1 O) 2 P(O)0]-, WO 2012/163489 PCT/EP2012/002179 - 90 [(R1O)P(O)02] 2 , [(R 1 0)R 1 P(O)O]~, tosylate, malonate which may be substituted by straight-chain or branched alkyl groups having 1 to 4 C atoms, [HOCO 2 ] or [C03] 2-, with the proviso that [SO 4 ] 2- and [CO 3 ] 2 ~ are used merely for the synthesis of compounds of formula I having 5 another metal cation than the alkali metal cation of the compound of formula 1-1, in which R, is each independently of another a straight-chain or branched alkyl group having 1 to 12 C atoms and R 2 is each independently of one another a straight-chain or branched 10 perfluorinated alkyl group having 1 to 12 C atoms and where electroneutrality should be taken into consideration in the formula of the salt KtA.
8. An electrolyte formulation comprising at least one compound of formula 15 I according to one or more of claims 1 to 3.
9. An electrochemical and/or optoelectronic device comprising an electrolyte formulation according to claim 7. 20
10. Use of compounds of formula I according to one or more of claims 1 to 3 in which [Kt]z+ is an organic cation or H 4 and z is 1, 2, 3 or 4 as media for chemical reactions, as catalyst and/or as media in catalytical processes, as conducting salts, as components of electrolytes for the application in electrochemical cells, as components of supporting 25 electrolytes for electrochemical processes, as surfactants, as phase transfer catalysts, as trainer, as extractant; as antistatic additive, as plasticiser; as heat-transfer-medium, as modifier for membranes and textile materials; as lubricant, as additive to lubricant compositions or to another engineering fluids; as hydraulic fluid or as additive to hydraulic 30 fluids. WO 2012/163489 PCT/EP2012/002179 - 91
11. Use of compounds of formula I according to one or more of claims 1 to 3 in which [Kt]z+ is a cation of formula (2), (5), (6), (9), tritylium, pyrylium, 1-benzopyrylium or 2-benzopyrylium as cationic polymerization initiator, photo-polymerization initiator or photo-acid 5 generator.
12. Use of compounds of formula 1-1 [Me]' [BH(CN) 3 ]~ I-1 in which [Me]* is an alkali metal cation including sodium hydrido 10 tricyano-borate and potassium hydrido-tricyano-borate for the synthesis of compounds of formula I according to one or more of claims 1 to 3 in which [Kt]z+ is an organic cation and z is 1, 2, 3 or 4.
13. Compounds of formula Ill 15 {[Me]*} 2 [B(CN) 3 ] 2 - ll in which [Me]+ denotes an alkali metal cation.
14. Process for the preparation of a compound of formula Ill according to claim 12 comprising the reaction of a compound of formula 11 20 [Me']* [B(CN)4] 1 in which [Me']+ denotes an alkali metal cation with an alkali metal [Me'] in which the alkali metal [Me'] and the alkali metal cation [Me']* are the same or different. 25
15. Use of compounds according to claim 12 for the introduction of B(CN) 3 groups in chemical substances. 30
AU2012265219A 2011-05-31 2012-05-23 Compounds containing hydrido-tricyano-borate anions Ceased AU2012265219B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11004431 2011-05-31
EP11004431.0 2011-05-31
PCT/EP2012/002179 WO2012163489A1 (en) 2011-05-31 2012-05-23 Compounds containing hydrido-tricyano-borate anions

Publications (3)

Publication Number Publication Date
AU2012265219A1 true AU2012265219A1 (en) 2014-01-16
AU2012265219A8 AU2012265219A8 (en) 2014-02-06
AU2012265219B2 AU2012265219B2 (en) 2017-02-16

Family

ID=46149387

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012265219A Ceased AU2012265219B2 (en) 2011-05-31 2012-05-23 Compounds containing hydrido-tricyano-borate anions

Country Status (11)

Country Link
US (2) US9518068B2 (en)
EP (1) EP2714698B1 (en)
JP (1) JP5990262B2 (en)
KR (1) KR20140034256A (en)
CN (1) CN103582647A (en)
AU (1) AU2012265219B2 (en)
BR (1) BR112013030741A2 (en)
IL (1) IL229328A (en)
SG (1) SG195086A1 (en)
TW (1) TWI567084B (en)
WO (1) WO2012163489A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2925768B1 (en) * 2012-11-30 2016-12-21 Merck Patent GmbH Cobaltcomplex salts
EP2925767A1 (en) * 2012-11-30 2015-10-07 Merck Patent GmbH Cobalt complexes with tricyanoborate or dicyanoborate counter-anions for electrochemical or optoelectronic devices
DE102013009959A1 (en) 2013-06-14 2014-12-31 Julius-Maximilians-Universität Würzburg Process for the preparation of salts with hydridocyanoborate anions
DE102013013502A1 (en) * 2013-08-16 2015-03-12 Julius-Maximilians-Universität Würzburg Hexacyanodiborate
DE102014008131A1 (en) * 2014-06-06 2015-12-17 Julius-Maximilians-Universität Würzburg Process for the preparation of salts with monoyidobiocyanoborate anions
DE102014011089A1 (en) 2014-07-30 2016-02-04 Julius-Maximilians-Universität Würzburg Process for the preparation of salts with hydridocyanoborate anions
DE102014014967A1 (en) 2014-10-14 2016-04-14 Julius-Maximilians-Universität Würzburg Process for the preparation of compounds with monofluorotricyanoborate anions
DE102014016681A1 (en) 2014-11-12 2016-05-12 Julius-Maximilians-Universität Würzburg Process for the preparation of salts with hydridocyanoborate anions
DE102014018103A1 (en) 2014-12-09 2016-06-09 Julius-Maximilians-Universität Würzburg Process for the preparation of compounds with tricyanoborate dianions
CA3001974A1 (en) 2015-10-14 2017-04-20 Bristol-Myers Squibb Company 2,4-dihydroxy-nicotinamides as apj agonists
CN106750839B (en) * 2015-11-20 2019-04-05 中国石油天然气股份有限公司 Special material for drip irrigation belt and preparation method thereof
JP6948322B2 (en) 2015-12-16 2021-10-13 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Heteroarylhydroxypyrimidinone as an APJ agonist of APJ receptor
CN109195963B (en) 2016-03-24 2021-04-23 百时美施贵宝公司 6-hydroxy-4-oxo-1, 4-dihydropyrimidine-5-carboxamides as APJ agonists
CA3026149A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
DE102016009846A1 (en) 2016-08-16 2018-02-22 Julius-Maximilians-Universität Würzburg Fluoroalkylhydrido and fluoroalkylcyanohydridoborates
DE102016010488A1 (en) 2016-08-30 2018-03-01 Julius-Maximilians-Universität Würzburg Compounds with mono-, bis- and multiply charged weakly coordinating anions
EP3571193B1 (en) 2017-01-23 2021-12-01 Cadent Therapeutics, Inc. Potassium channel modulators
PT3762368T (en) 2018-03-08 2022-05-06 Incyte Corp Aminopyrazine diol compounds as pi3k-y inhibitors
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
KR20210057053A (en) 2018-08-23 2021-05-20 씨젠 인크. Anti-TIGIT antibody
MA53978A (en) 2018-10-22 2021-09-01 Cadent Therapeutics Inc CRYSTALLINE FORMS OF POTASSIUM CHANNEL MODULATORS
WO2020219049A1 (en) * 2019-04-25 2020-10-29 Exxonmobil Chemical Patents Inc. Non-coordinating anion type indolinium activators in aliphatic and alicyclic hydrocarbon solvents
AU2022380979A1 (en) 2021-11-02 2024-06-06 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10055811A1 (en) * 2000-11-10 2002-05-29 Merck Patent Gmbh Tetrakisfluoroalkylborate salts and their use as conductive salts
US7713658B2 (en) 2002-04-02 2010-05-11 Nippon Shokubai Co., Ltd. Material for electrolytic solutions and use thereof
JP4439797B2 (en) * 2002-10-03 2010-03-24 株式会社日本触媒 Ion conductor materials
JP2004123653A (en) * 2002-10-04 2004-04-22 Nippon Shokubai Co Ltd Method for producing ionic material
JP2004123652A (en) * 2002-10-04 2004-04-22 Nippon Shokubai Co Ltd Method for producing ionic material
EP1528580B2 (en) 2003-01-15 2015-07-01 Nippon Shokubai Co., Ltd. Dye-sensitized type solar cell
DE10306617A1 (en) * 2003-02-14 2004-08-26 Merck Patent Gmbh New organic cyanoborates, used as ionic liquid, non-aqueous electrolyte, phase transfer catalyst or intermediate e.g. for liquid crystal compound, pharmaceutical or plant protection agent, are prepared via alkali metal salt
JP2006173014A (en) * 2004-12-17 2006-06-29 Nippon Shokubai Co Ltd Ionic material-contained composition, ion conductive material, and use thereof
JP4883903B2 (en) * 2004-05-10 2012-02-22 株式会社日本触媒 Electrolyte material
CN1331840C (en) 2004-11-11 2007-08-15 中国科学院大连化学物理研究所 Catalytic synthesis of phenylhydroxylamine compound
JP2006202646A (en) * 2005-01-21 2006-08-03 Nippon Shokubai Co Ltd Ionic liquid composition, ion-conductive material, and electrolyte material
JP2007134184A (en) * 2005-11-10 2007-05-31 Nippon Shokubai Co Ltd Ionic composition
JP4187113B2 (en) * 2006-12-25 2008-11-26 株式会社日本触媒 Ionic compounds
JP5913804B2 (en) * 2008-08-22 2016-04-27 日宝化学株式会社 Ionic compound, method for producing the same, and ion conductive material using the same
EA020216B1 (en) * 2009-02-02 2014-09-30 Лонца Лтд. Tricyanoborates, preparation thereof and use thereof as ionic liquid
KR20110120286A (en) * 2009-02-12 2011-11-03 아스텔라스세이야쿠 가부시키가이샤 Hetero ring derivative

Also Published As

Publication number Publication date
KR20140034256A (en) 2014-03-19
AU2012265219B2 (en) 2017-02-16
EP2714698B1 (en) 2016-11-09
WO2012163489A1 (en) 2012-12-06
US9518068B2 (en) 2016-12-13
CN103582647A (en) 2014-02-12
IL229328A (en) 2016-09-29
SG195086A1 (en) 2013-12-30
IL229328A0 (en) 2014-01-30
BR112013030741A2 (en) 2016-12-06
JP2014522397A (en) 2014-09-04
JP5990262B2 (en) 2016-09-07
TW201311708A (en) 2013-03-16
US20140107341A1 (en) 2014-04-17
AU2012265219A8 (en) 2014-02-06
TWI567084B (en) 2017-01-21
EP2714698A1 (en) 2014-04-09
US20160167972A1 (en) 2016-06-16
US9409925B2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
US9409925B2 (en) Compounds containing hydrido-tricyano-borate anions
EP2731955B1 (en) Compounds containing alkyl-cyano-borate or alkyl-cyano-fluoroborate anions
AU2012265220A1 (en) Electrolyte formulations
JP5950916B2 (en) Electrolyte formulation comprising cyano-alkoxy-borate anion
EP2526106B1 (en) Compounds containing perfluoroalkyl-cyano-alkoxy-borate anions or perfluoroalkyl-cyano-alkoxy-fluoro-borate anions
US8859800B2 (en) Compounds containing alkyl-alkoxy-cyano-borate anions

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 28 , NO 2 , PAGE(S) 271 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME MERCK PATENT GMBH APPLICATION NO 2012265219, UNDER INID (72) CORRECT THE CO-INVENTOR TO IGNATYEV, NIKOLAI (MYKOLA)

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired